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Abstract 
Background 
Internet-accessed STI (e-STI) testing is recommended in England to expand access to STI 
testing services, particularly among high-risk groups. Yet the evidence for the effectiveness 
of this testing modality is limited. This thesis aimed to address this evidence gap, by 
evaluating the effects of an e-STI testing and results service (SH:24) on STI diagnoses and 
STI testing uptake, when delivered alongside usual care in two London boroughs. 
Theoretical premise of thesis 
In line with theory-driven approaches to evaluation, I developed an explanatory framework 
outlining hypothesised change processes that may be triggered by the intervention. I 
adopted a critical realist conceptualisation of causal mechanisms and I drew on the 
‘candidacy’ lens to conceptualise change processes in relation to access and utilisation of 
STI testing services.  I then used this framework to situate the evaluation findings. 
Methods 
This evaluation was based on a randomised controlled trial (RCT). 2,072 individuals aged 
16–30 years, resident in Lambeth and Southwark, with at least one sexual partner in the 
previous 12 months and willing to take an STI test, were recruited in community settings. 
Participants were allocated to an e-STI testing service (intervention) or to a website with 
signposting to local sexual health clinics (control). The e-STI testing service provided postal 
self-sampling kits for chlamydia, gonorrhoea, HIV and syphilis. Results were delivered via 
text message or phone, and participants were signposted to local clinics for confirmatory 
testing and treatment as necessary. 
Results  
The published trial results are as follows:  1,031 participants in the intervention group and 
1,032 control group were included in the analyses.  At 6 weeks, 50.0% of the intervention 
group completed an STI test compared to 26.6% in the control group (relative risk, RR 1.87, 
95% confidence interval 1.63 to 2.15, p<0.001). 2.8% of the intervention v 1.4% in the 
control were diagnosed with an STI (RR 2.10, 95% confidence interval 0.94 to 4.70, 
p=0.079). The effect on the proportion of participants treated was 1.1% in the intervention 
v 0.7% in the control (RR 1.72, 95% confidence interval 0.71 to 4.16, p=0.231). 
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Secondary analyses (unpublished at the time of writing) demonstrated that the 
intervention was effective for uptake of STI testing among a subsample of participants who 
had never previously tested for STIs.  
Conclusions  
The findings lend weight to national policies in England, which promote e-STI testing as a 
means to increase utilisation of STI testing services, particularly among groups who do not 
use conventional services. While the results support the candidacy model’s processual 
framing of health care utilisation, further research is required to understand how the 
construct of candidacy is recognised and negotiated within a digital service environment by 
different socio-demographic groups. In addition, larger trials are needed to assess 
outcomes later in the cascade of care.   
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Chapter 1: STI epidemiology and sexual health 
services 
1.1 Chapter overview 
In this chapter, I review the epidemiological data on STIs in England and the United 
Kingdom (UK), including the risk profiles of key population groups. I present an overview of 
STI testing services in England, and I introduce internet-accessed STI testing (e-STI testing) 
as a novel, but emerging, component of service delivery systems. Finally, I review the 
international evidence base for e-STI testing.         
1.2 Introduction  
Sexually transmitted infections (STIs) are an important cause of morbidity and mortality 
worldwide, and a key indicator of sexual ill health. Globally, there are 357 million new 
infections of curable STIs (chlamydia, gonorrhoea, syphilis, and trichomonas vaginalis) each 
year (World Health Organisation no date). While global incidence rates of HIV infection are 
on the decline, prevalence remains significant: UNAIDS estimated 1.8 million new HIV 
infections in 2016 and that 36.7 million people were living with HIV (Joint United Nations 
Programme on HIV/AIDS 2017).  
Left undiagnosed and untreated, curable STIs such as chlamydia, trichomoniasis, 
gonorrhoea and syphilis can facilitate the transmission of HIV and can cause sub-fertility, 
ectopic pregnancy, chronic pelvic pain, neurological and cardiovascular disease, neonatal 
mortality, and infant morbidities (Holmes KT et al. 2008). Undiagnosed HIV and late 
diagnosis of HIV lead to diminished health outcomes and reduced life expectancy (Mocroft 
et al. 2013). 
Increasing testing, diagnosis, and treatment of STIs and reducing time to treatment is a 
global priority to reduce the prevalence of STIs and their associated sequelae (World Health 
Organisation; United Kingdom Department of Health 2013). In the UK, testing coverage 
remains sub-optimal. The 3rd National Survey of Sexual Attitudes and Lifestyles (hereon 
referred to as NATSAL) found that two-thirds of 16-44 year olds who tested positive for 
chlamydia had not had a chlamydia test in the past 12 months (Sonnenberg et al. 2013).  
Further, timely diagnosis of HIV is a challenge. In 2016, 41% of adults diagnosed with HIV in 
the UK were diagnosed late (CD4 count < 350 cells/mm3) (Public Health England 2017e). 
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Interventions that increase access among high-risk and hard-to-reach groups are needed to 
maximise the public health benefits of ‘test and treat’ strategies for STIs.  
1.3 STI epidemiology in England  
In 2016, there were 417,584 new STI diagnoses in England, comprised primarily of 
chlamydia (202,546), followed by anogenital warts (62,721), gonorrhoea (36,244), non-
specific genital infection (36,774) and herpes (31,860) (Public Health England 2017d).  
Comparable data suggest that between 2003 and 2012, there was a 47% increase in new 
diagnoses in England, from 305,000 to 448,000 diagnoses (Hughes & Field 2015). This trend 
has been driven by innovations in diagnostic technologies,  improved access to services, 
combined with an increased incidence of infection among specific populations (Hughes & 
Field 2015).   
Men who have sex with men (MSM), young heterosexuals and black minority ethnic groups 
continue to be disproportionately affected by STIs. The following sections outline the STI 
risk profiles of each of these populations. 
1.3.1 MSM 
In 2016, in England, 49,445 new STI diagnoses were in MSM (Public Health England 2017d). 
Among male attendees of sexual health clinics, MSM accounted for 64.7% of gonorrhoea 
and 85.5% of syphilis diagnoses in 2016. Moreover, MSM account for the burden of all 
syphilis infection (Public Health England 2017b). Of the 5,920 new syphilis diagnoses in 
England in 2016, 80.9% (4,788) were in MSM (Public Health England 2017d).  
There is evidence of increasing incidence of syphilis and gonorrhoea among MSM. Between 
2012 and 2015, the overall diagnosis rate per 100,000 attendances rose from 114.7 to 
173.1 for syphilis; and from 1,027.2 to 1,348.2 for gonorrhoea (Public Health England 
2016b). These increases in diagnoses rates are concentrated in MSM (Public Health England 
2016b).  Rising incidence of gonorrhoea is of particular concern given the emerging 
evidence of antimicrobial gonococcal resistance (Public Health England 2016c). 
Compared to heterosexual men, MSM are more likely to report higher sexual risk 
behaviours. A study based on data from Natsal-3 found that MSM were more likely to 
report higher numbers of lifetime partners and more frequent partner change in the last 12 
months, compared to men who exclusively have sex with women (Mercer et al. 2016). 
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Further, MSM were over 3 times more likely to report condomless sex with two or more 
partners in the last 12 months compared to heterosexual men (adj OR 3.52, 95% CI 2.13–
5.83, p<0.001) (Mercer et al. 2016). 
Complex sexual networks that are dense in nature (i.e. higher contact rates) can facilitate 
rapid STI transmission among MSM (Doherty et al. 2005; Hart & Elford 2010). Unprotected 
anal intercourse, and particularly receptive unprotected anal intercourse, is associated with 
an elevated risk of infection compared to other sexual practices (McDaid & Hart 2010). 
Chemsex (sex under the influence of psychoactive substances), which is more common in 
London compared to the rest of the UK, is also linked to heightened sexual risk taking 
among MSM (Pufall et al. 2018; Bourne et al. 2015).  
1.3.2 Young adults 
Young adults, between 15 and 24 years of age, experience the highest rates of STI 
diagnoses per 100,000 population compared to all other age group (Figure 1). 
 
  
As illustrated in figure 1, a much higher proportion of young women aged 15-19 years are 
diagnosed with STIs compared to young men of the same age. This may be partly explained 
by sexual mixing patterns (Kraut-Becher & Aral 2006). Young heterosexual women tend to 
have older sexual partners (Mercer et al. 2009), who in turn have higher risk profiles than 
 Figure 1: Rates of new STI diagnoses by gender and age group, 2016 (Public Health 
England 2017c, Figure 3) 
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younger men. In Britain, population prevalence estimates for the most common STIs (HPV 
and chlamydia) are greater in older cohorts of men (20-24 years) compared to younger 
ones (18-19 years and 16-17 years) (Sonnenberg et al. 2013). Moreover, there is evidence 
that young women struggle to negotiate safe sex with older partners (Morrison‐Beedy, Xia 
& Passmore 2013). 
Among heterosexuals, young people account for the majority of diagnoses in chlamydia, 
gonorrhoea, genital warts and genital herpes. Among heterosexuals, 62% of chlamydia 
diagnoses in 2016 were in individuals aged 15-24 years (Public Health England 2017d). The 
burden of chlamydia infection among young adults is of particular concern and this has 
prompted the introduction of the National Chlamydia Screening Programme (NCSP) in 
England. Chlamydia infection is predominantly asymptomatic, and can easily remain 
undetected and untreated. Population based estimates, based on data from Natsal-3, 
indicated that among 16-24 year olds, chlamydia prevalence was 3.1% (95% CI 2.2% to 
4.3%) in women and 2.3% (1.5% to 3.4%) in men (Sonnenberg et al. 2013). Prevalent 
chlamydia infection is associated with increasing number of reported sexual partners. 
However, among those with prevalent chlamydia infection, an estimated 60.4% (95% CI 
45.5%–73.7%) of women and 43.3% (95% CI 25.9%–62.5%) of men reported only one sexual 
partner in the past 12 months (Ibid.). 
Undiagnosed and untreated chlamydia is estimated to be responsible for 16% (95% CrI, 6% 
- 25%) of clinical pelvic inflammatory disease (PID) (Price et al. 2013). Reinfection is also a 
key concern (Walker et al. 2012; LaMontagne et al. 2007). A study based on NCSP data from 
2010 found that among repeat testers (15-24 years), those with a positive baseline test had 
higher odds of testing positive compared to those with a negative baseline test (Males, 
adjusted OR 2.57, 95% CI 2.11 to 3.14, p<0.001; Females, adjusted OR 1.95, 95% CI 1.76 to 
2.16, p<0.001) (Woodhall et al. 2013).  
Key drivers of young peoples’ heightened susceptibility to STIs include more frequent 
partner change compared to older age groups (Mercer et al. 2013), as well as a lack of 
knowledge, skills and confidence to negotiate safe sex, including condom use (Marston & 
King 2006). Young adults also report barriers in accessing sexual health services in the UK 
(Oliver de Visser & O’Neill 2013; Normansell, Drennan & Oakeshott 2016). Attendance at 
sexual health services is lower among young men compared to young women. Analyses of 
Natsal-3 data found that 43.8% (95% CI 41.1–46.5) of women aged 16-24 reported 
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attending a sexual health clinic in the past 5 years compared to 31.4% (95% CI 28.6–34.4) of 
men (Sonnenberg et al. 2013). Further, in 2016, chlamydia test coverage among 15-24 year 
olds was only 12% among men compared to 30% among women (Public Health England 
2017d). 
The sexual repertoires of young people in Britain are in flux. Evidence from Natsal-3 
suggests that a higher proportion of sexually active young people are engaging in anal sex 
than in previous survey rounds (Lewis et al.). Qualitative research findings indicate that 
health promotion messaging is not aligned with these changing repertoires (Marston & 
Lewis 2014). 
1.3.3 Black and minority ethnic groups   
Black Caribbean and black African minorities have substantially higher rates of STIs, 
including gonorrhoea, genital warts and trichimoniasis, compared to other ethnic groups in 
the population (Public Health England 2017d).  
A heightened risk of infection among black ethnic minorities is also reported by population 
based probability studies, though not to the same magnitude as studies based on 
surveillance data.  A study using Natsal-2 data found that compared to white men, black 
Caribbean and black African men were more than twice as likely to report an STI diagnosis 
in the last 5 years; and similar associations were reported among women (Fenton et al. 
2005).  
A subsequent study based on Natsal-3 data, found that a higher proportion of black 
minority groups reported attending a sexual health clinic in the last 5 years than white 
British groups.  These proportions are as follows: 23.6% of black Caribbean and 19.8% of 
black African men compared to 11.8% of white British men; and 26.8% of black Caribbean 
women compared to 12.7% of white British women. However, compared to black African 
men, a lower proportion of black African women reported clinic attendance (14.6%) (Wayal 
et al. 2017).  
Yet these findings are not an assurance of equity. Such comparisons can mask barriers to 
care experienced by the dominant referent group (Dixon-Woods et al. 2005); and utilisation 
of services among black minority groups may still be inadequate relative to need. Indeed, as 
highlighted later, late diagnoses of HIV among black African heterosexuals is still a concern. 
Qualitative research has highlighted discriminatory attitudes among health providers 
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towards minority ethnic groups, which may deter some people from seeking care (Connell, 
McKevitt & Low 2004). 
Research on the determinants of sexual health inequalities by ethnicity is lacking in the UK 
(Wayal et al. 2017; Jewkes & Dunkle 2017). Analyses of Natsal-2 data has shown that the 
elevated risk of infection among black minority groups is partially, but not fully, explained 
by associated socio-economic disparities, such as area level deprivation (Furegato et al. 
2016), and individual sexual health behaviours (e.g. higher number of lifetime sexual 
partners relative to other ethnic groups) (Fenton et al. 2005; Wayal et al. 2017). Additional 
factors including gender dynamics and sexual mixing patterns specific to particular cultural 
groups are believed to play a contributory role and warrant further investigation (Jewkes & 
Dunkle 2017; Wayal et al. 2017; Fenton et al. 2005) . 
1.4 HIV in England and the UK 
In 2016, an estimated 89,400 (Credible interval (CrI) 87,200 to 94,700) people were living 
with HIV in England, of whom 10,400 (CrI 8,400 to 15,700) remain undiagnosed (Brown et 
al. 2017a).  
The overall prevalence of HIV in England is 2.2 (Crl 2.1-2.3) per 1,000 population aged 15-
74. The burden of infection is concentrated in MSM and black African heterosexuals. 
Among MSM aged 15-59 years, the estimated prevalence is 77 (Crl 69-86) per 1,000 
population; and 23 (CrI 22-25) per 1,000 among black African heterosexual men and 34 (CrI 
34-35) per 1,000 among black African heterosexual women (Brown et al. 2017a).  
However, new HIV diagnoses in both these populations have declined in recent years. In 
England, in 2016 there was an overall 18% decline in HIV diagnoses from the previous year 
(5,152 new diagnoses in 2016 versus 6,278 diagnoses in 2015)(Public Health England 
2017e); and this was driven by a sharp fall in diagnoses among MSM (Brown et al. 2017a). 
This trend was most apparent in five high volume GUM clinics in London (Dean Street, 
Mortimer Market, Homerton, St Mary’s and St Thomas’), where HIV diagnoses in MSM fell 
by 35% (from 1,034 in 2015 to 672 in 2016) (Brown et al. 2017a). An increased volume of 
HIV testing, particularly repeat testing, combined with rapid access to treatment is believed 
to have contributed to a reduction in HIV transmission among MSM. The availability of pre-
exposure prophylaxis (PrEP), although still limited in the UK, is also thought to have played 
a role (Brown et al. 2017b).     
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The absolute numbers of new diagnoses among black African heterosexual men and 
women in the UK has dropped from 2,664 in 2007 to 669 in 2016 (Brown et al. 2017a). This 
is accompanied by a shift in the ethnic distribution of new HIV diagnoses overall. In 2007, 
68% of heterosexual adults with a new HIV diagnoses were of black African ethnicity 
compared to 39% in 2016. Conversely, the proportion attributable to those of white 
ethnicity has increased (although the absolute number of white heterosexuals diagnosed 
with HIV has remained fairly constant). This trend can be explained by changing migration 
patterns, as fewer people from areas of high HIV prevalence, including sub Saharan Africa, 
have migrated to the UK in recent years (Brown et al. 2017a). 
The proportion of diagnoses at a late stage of infection (CD4 count <350 cells/mm3 within 
91 days of diagnosis) has declined by 45% since 2007. Yet late diagnoses are still a serious 
concern. In 2016, 41% of diagnosed adults were diagnosed late in England (Public Health 
England 2017e).  Proportions of late diagnoses were highest among black African 
heterosexual men (139/215, 65%) and women (165/335, 49%); and lowest among MSM 
(663/2,096, 32%) (Brown et al. 2017a).  
1.5 STI testing services in England  
Similar to other industrialised countries, ‘test and treat’ is a core strategy for the control 
and management of STIs in England and the rest of the UK. Ensuring rapid access to STI 
testing services is a central pillar of England’s framework for sexual health improvement 
(United Kingdom Department of Health 2013). Rapid access is defined as those seeking care 
are attended by a health professional within two working days of contacting a service 
(British Association for Sexual Health and HIV & Medical Foundation for HIV & Sexual 
Health 2014). Early diagnosis allows for timely detection and treatment of infection, 
preventing onward transmission and its associated sequelae. 
Further, prompt detection of HIV allows early initiation of antiretroviral therapy (ART). Early 
initiation optimises clinical outcomes for affected individuals, while supporting prevention 
efforts by reducing the viral load at the population level (Mocroft et al. 2013).  The 
expansion of HIV testing is also key for widening access to other therapeutic interventions, 
including PrEP (McDaid et al. 2016). 
These secondary prevention measures are complemented by additional prevention 
initiatives, including sex and relationship education (SRE) in schools, health promotion and 
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behaviour change campaigns, including access to condoms (Clutterbuck et al. 2012; Public 
Health England 2015a).  
Local authorities in England have a statutory obligation to provide ‘open access’ STI testing 
and treatment service (Department of Health 2013). An open access policy permits people 
to attend any commissioned service regardless of the location of the service or their own 
area of residence (ibid.). Individuals concerned they may have acquired an infection, or who 
choose to test regularly, can self-refer into specialist GUM and community based sexual and 
reproductive health clinics, as well non-specialist primary care facilities (e.g. GP surgeries). 
Tests are also available in community settings such as universities and sports centres. These 
employ a range of diagnostic technologies including point of care tests, as well as self-
testing and self-sampling testing modalities.  
Publicly funded STI testing and treatment services are free at point of use. Particular 
emphasis is placed on encouraging regular testing among groups most at risk, including 
young people, MSM and black minority ethnic groups.  A summary of recommended testing 
frequencies by risk group is presented in the table below. 
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Table 1. Public Health England recommended testing frequencies by risk group 
Men who have sex with men  Test for HIV and STIs each year, and every 3 months if having 
condomless sex with new or casual partners 
Young adults who are sexually active (aged 
15-24 years) 
Screen for chlamydia annually, and on change of sexual 
partner 
Black ethnic minority men and women Regular STI screen, including HIV, if having condomless sex 
with new or casual partners  
Source: Public Health England (2017d) 
As mentioned earlier, an opportunistic screening programme for chlamydia was established 
in England in 2003 (National Chlamydia Screening Programme - NCSP). The NCSP stipulates 
that young adults between 15-24 years, who attend sexual health services, primary health 
care or other community facilities should be offered an annual test for chlamydia or on 
change of sexual partner (Public Health England 2016a).  
National guidelines also recommend the expansion of HIV testing outwith specialist settings 
in areas of high HIV prevalence, defined as between 2 to 5 prevalent cases per 1,000 
population aged 16-59 years (National Institute for Health and Care Excellence 2016).  This 
includes routine testing among adults admitted to hospital who are undergoing blood tests 
and routine testing of all new patients at GP surgeries. GPs are also advised to offer HIV 
testing to all patients undergoing blood tests and who have not tested for HIV in the 
previous 12 months (National Institute for Health and Care Excellence 2016). This strategy 
reflects efforts to reach high-risk groups who do not attend specialist sexual health services, 
or who present to services late. Indeed, there is evidence of missed opportunities to 
diagnose black African patients in London, who had attended primary care facilities prior to 
their HIV diagnosis in specialist settings (Burns et al. 2008).  Geographical targeting also 
serves to normalise HIV testing in areas most affected by HIV.  
Nevertheless, most STI testing (including HIV) continues to take place in specialist GUM 
clinics, with the exception of chlamydia testing (Public Health England 2017a; Public Health 
England 2017d).  In 2016 more than half (59%) of chlamydia testing among 15-24 year olds 
took place outwith GUM clinics, including primary care and community settings, yielding 
approximately 50% of all chlamydia diagnoses among this age group (Public Health England 
2017d).  
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The quality of STI testing provision in the UK is difficult to gauge. The British Association for 
Sexual Health and HIV (BASHH) and HIV Medical Foundation for AIDS Sexual Health 
(MEDFASH) published standards for the management of STIs in 2010 (British Association for 
Sexual Health and HIV & Medical Foundation for HIV & Sexual Health 2014); and a national 
audit of sexual health services was conducted in the UK in 2011. Participation was voluntary 
and the audit suffered from low response rates (60% of GUM clinics and 8% of lower level 
clinics in the UK returned data). Areas of low performance included poor care linkages 
between non-specialist and GUM clinics; and low proportions of clinic attendees offered 
HIV tests. A high proportion of GUM clinics (86%), but not lower tier clinics (51%), met the 
quality standard for providing an appointment within 48 hours (McClean et al. 2012). It 
should be noted however, that since 2010 the 48 hour access standard is no longer a legal 
requirement (Foley et al. 2017), leading to concerns that progress achieved on reducing 
patient delays may be compromised (ibid.). 
Since the restructuring of sexual and reproductive health services in England, mandated by 
the 2012 Health and Social Care Act, there has been increasing concern regarding the 
fragmentation of services and the ensuing impact on patient care (Public Health England 
2017c). Commissioning of sexual, reproductive health and HIV services is divided between 
Clinical Commissioning Groups (CCGs), Local Authorities and Central Government (NHS 
England). Sexual health and HIV commissioning responsibilities are summarised as follows:  
Table 2. Commissioning roles for sexual, reproductive and HIV services in England 
Local Authorities NHS England CCGs 
STI testing and treatment 
Chlamydia screening 
Young people’s sexual health services 
Services in schools 
Sexual health aspects of psychosexual 
counselling 
Sexual health advice, promotion and 
prevention 
STI testing and treatment 
provided under the GP contract 
 
HIV testing, prevention, and social care HIV treatment and care 
HIV testing when required in 
other NHS England-
commissioned services 
HIV testing when 
required in other CCG 
commissioned services 
Community-based HIV 
clinical nurse specialists 
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Sources: Adapted from All-Party Parliamentary Group on Sexual and Reproductive Health in the UK 
(2015) & Robertson et al. (2017)   
As a result of these reforms, key services have become decoupled (for example HIV testing 
is commissioned separately from HIV treatment services); and a lack of collaboration 
between multiple commissioning entities has led to disjointed care pathways in some 
regions (Public Health England 2017c; Robertson et al. 2017).  Moreover, local authorities 
are struggling with severe budget cuts against a backdrop of unprecedented demand for STI 
testing services. Local authority spending on STI testing and treatment services dropped by 
3.5% in cash terms between 2014/2015 and 2015/2016  (Robertson et al. 2017, p.30); and a 
quarter of local authorities in England reduced spending by as much as 20% (Robertson et 
al. 2017, p.30).  Further, in this context of unprecedented change, there are concerns 
regarding the lack of minimum standards for providers, in addition to confused lines of 
accountability within commissioning structures (All-Party Parliamentary Group on Sexual 
and Reproductive Health in the UK 2015). 
1.6 STI testing coverage in England 
Surveillance data has demonstrated an upward trend in attendances at sexual health 
services (Hughes & Field 2015), and this finding is echoed in population-based data. 
Sonnenberg and colleagues (2013) reported that between Natsal-1 and Natsal-3, the 
proportion of sexually active men attending a sexual health clinic in the previous  5 years 
rose from 4.4% (95% CI, 3.8-5.0) to 19.6% (95% CI, 18.2-21.2); and among women from 
3.4% (95% CI, 2.9-4.0) to 21.4% (95% CI, 20.1-22.7).  
England is performing well against the international benchmarks for HIV testing and 
treatment (90:90:90), set by Joint United Nations Programme on HIV/AIDS (2014). The 
targets are as follows: 
By the year 2020 
- 90% of people living with HIV diagnosed;  
- 90% of people diagnosed receiving treatment; 
- 90% of those on treatment being virally supressed. 
In 2016, these targets were met for the first time in London (90%, 97%, 97%), while at a 
national level, England was behind on testing coverage (88%) but reached the targets for 
treatment (96% diagnosed receiving treatment and 97% on treatment virally supressed) 
(Brown et al. 2017a). 
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Nevertheless, national indicators suggest that STI testing coverage is sub-optimal in 
England. The Public Health Outcomes Framework (PHOF) monitors two indicators related to 
STI testing: the chlamydia detection rate among 15-24 year olds and the proportion of 
adults diagnosed with HIV at a late stage of infection (CD4 count <350 cells/mm3 within 91 
days of diagnosis). In 2016, the chlamydia detection rate was 1,882 per 100,000 population 
(15-24 years) in England, which is well below the target of at least 2,300 per 100,000 
population. Only 22% of local authorities in England achieved this national target in the 
same year (Public Health England 2017d). Furthermore, 41% of adults with an HIV diagnosis 
were diagnosed late in 2016, which is much higher than the national target of 25% (Public 
Health England 2017e).   
Evidence from national surveys indicates that key population groups are not testing with 
sufficient frequency. Analysis of Natsal-3 data found that between 2010 and 2012, only 27% 
(95% CI 19–37) of sexually active MSM in Britain had tested for HIV in the previous 12 
months (Sonnenberg et al. 2013), despite national guidelines that recommend annual 
testing among this group (Table 1).  More recent surveys, based on convenience samples, 
support this finding. Witzel and colleagues analysed a large sample of MSM (n=14,317) 
recruited as part of the 2014 Gay Men’s Sex Survey. They found that 26% had never tested 
for HIV (Witzel et al. 2016).  
The current chlamydia detection rate is an indication of insufficient test coverage among 
young adults overall. Moreover, recent evidence has demonstrated that coverage 
continues to be suboptimal even among those at heightened risk of infection. Using data 
from Natsal-3, Woodhall and colleagues reported that 25.8% of women and 51.2% of men 
(aged 16-24 years) who reported condomless sex with two or more partners in the previous 
12 months, had not tested for chlamydia during the same period (Woodhall et al. 2015). 
This suggests that screening effects should be intensified to ensure those most at risk of 
infection are reached (Lewis & White 2018; Woodhall et al. 2015). 
Sexually active young adults and MSM are advised to test annually irrespective of sexual 
risk practices, while it is recommended that black African individuals test regularly if having 
condomless sex with new or casual partners (Table 1). As discussed earlier, a higher 
proportion of black African adults, diagnosed with HIV, are diagnosed at a late stage of 
infection, relative to other risk groups. This is a clear indication that many at risk of 
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infection in this population subgroup, delay in seeking diagnostic testing for STIs.  The 
following section discusses barriers to care-seeking for STIs.  
1.7 Barriers to STI testing  
1.7.1 Risk perception  
Both national probability and community-based surveys have demonstrated a positive 
relationship between reported number of sexual partners (a key marker of sexual risk) and 
attendance at sexual health clinics (Sonnenberg et al. 2013; McDaid et al. 2016; Witzel et al. 
2016).  
However, low perception of sexual risk inhibits care-seeking for sexual health (Oliver de 
Visser & O’Neill 2013; Deblonde et al. 2010; Balfe et al. 2010a) , and crucially risk-
perception does not always marry with reported sexual behaviours. Clifton and colleagues, 
using data from Natsal-3, found that among MSM and black African groups who reported 
unsafe sex in the previous year (condomless sex with a new partner), most perceived 
themselves to be low risk of HIV: 83.2% (68.6 - 91.9) of MSM and 89.3% (74.5 -96.0) of 
black African heterosexuals (Clifton et al. 2016).   Findings from qualitative studies suggest 
that while there is high awareness of HIV among these populations in the UK, this has not 
necessarily translated into a perception of individual risk (Burns et al. 2007).  
Similarly, qualitative research with young women in Ireland found a disconnect between 
sexual risk practices and perceived need for chlamydia testing, as seeking an STI test did not 
fit with women’s social identities as ‘responsible moral agents’ (Balfe et al. 2010a, p.138).  
1.7.2 Stigma  
Stigma is understood to be the key barrier to help-seeking for sexual health (Hood & 
Friedman 2011). Stigma is broadly conceived as a ‘spoiled’ or ‘tainted’ identity that 
symbolises a person’s undesirable or risky ‘otherness‘ (Goffman 1963). Sexual practices and 
illnesses associated with sex carry particular connotations of ‘otherness’ and social risk. 
Rhodes and Cusack (2002, p.212) posit that accounts of sexual behaviour are ‘inevitably 
morally charged’  particularly if individuals are engaged in high-risk practices that may be 
judged as irresponsible and derelict of a civil duty to moderate risky behaviour.  
Experiences of stigma are influenced and moderated by factors such as age, sexual identity, 
ethnicity and socio-economic status. Gay and bisexual men have reported specific anxieties 
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around disclosing their sexual identities to health care providers and this may be more 
pronounced among younger men (Datta et al. 2018). Young people can be fearful that their 
sexual practices will be deemed inappropriate for their age, and inconsistent with socially 
prescribed gender roles (Balfe & Brugha 2009).  A key-informant study highlighted a 
particular concern among black African groups that health professionals may disclose a 
potential HIV diagnosis to the wider community (Burns et al. 2007).  
The social significance of infection can drive a fear of a positive diagnosis. HIV carries 
particular connotations of ‘tainted’ identity (Goffman 1963), as it is historically associated 
with the ‘unhealthy’, ‘sexually deviant’ and ‘contagious’ (Crawford 1994, p1347). Denial and 
avoidance are therefore common coping strategies among individuals with possible 
exposure to HIV (Lorenc et al. 2011).   
Specialist GUM clinics are viewed as socially undesirable spaces by some groups (Scoular, 
Duncan & Hart 2001) prompting a preference for testing in primary care settings among 
Irish women (Balfe et al. 2010b) and black Africans in London (Burns et al. 2007). However, 
young women in London have expressed preference for specialist clinics as primary care 
facilities are deemed to lack expertise (Normansell, Drennan & Oakeshott 2016); and 
similar findings have been reported by a discrete choice experiment study  with participants 
with a range of socio-demographic characteristics (Llewellyn et al. 2012).  
1.7.3 Convenience and accessibility  
Physical inaccessibility, long waiting times and unfriendly staff attitudes are all barriers to 
attendance (Llewellyn et al. 2012). Lengthy waits are commonly cited in relation to 
specialist sexual health clinics (Normansell, Drennan & Oakeshott 2016; Llewellyn et al. 
2012). Perceived delays in receiving test results also serve to heighten anxieties around STI 
testing (Lorenc et al. 2011).    
1.8 The emergence of e-Sexual health services  
1.8.1 Digital health and the patient-centred care agenda in the UK 
There is a strong commitment to digital health in the UK (NHS England 2014). Digital 
technology is viewed as a powerful enabler of the patient centred care agenda (Lupton 
2013). In the UK, patient-centred care is framed as part of a normative agenda to increase 
provider choice and patient involvement through the promotion of equal ‘partnerships’ 
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(Mead & Bower 2000) and models of ‘shared decision-making’ between patients and 
clinicians (United Kingdom Department of Health 2010; Coulter & Collins 2011).  
This is particularly evident in the area of chronic disease, where dedicated ‘expert patient’ 
programmes have proliferated, encouraging patients to exercise greater autonomy through 
the self-management of their condition (United Kingdom Department of Health 2001). This 
marks a departure from traditional paternalistic models of care in medicine, and the 
Parsonian framing of the patient as ‘passive’ and ‘dependent’ within the context of the 
clinical encounter (Armstrong 2014). 
Demands to reconfigure the power dynamics within the clinical context can be traced to 
the social movements of the 1960s and 1970s (Rothman 2001). Feminist activists in 
particular, were instrumental in exposing the limited agency of women to define and realise 
their own health needs (ibid.). Calls for greater autonomy, information and choice in health 
have also been increasingly articulated by a burgeoning consumer movement (Kapp 2009; 
Fox & Ward 2006). This movement espouses a free market model of health care, 
championing an ideal of ‘patient as consumer’, equipped with the power of choice and 
knowledge within a competitive marketplace (Lupton 1997; Fox & Ward 2006) . 
Yet there is uncertainty as to how the construct of ‘patient autonomy’ - a core ideal of the 
patient-centred paradigm - is both theoretically conceived and empirically practiced. In broad 
philosophical terms, autonomy encompasses ‘a certain idea of persons as self-determining’ 
(Dworkin 1988, p.11); and in the bioethical literature, patient autonomy is commonly 
considered in relation to the doctrine of informed consent, which safeguards patients’ rights 
to ‘be treated as persons, as masters of their own body, as responsible for their decisions, as 
makers of choices’ (Dworkin 1988, p.103).  
The limits and boundaries of autonomous action from a bioethical standpoint is subject to 
much debate. Clinicians may question patients’ abilities to understand the complexity of 
the medical information under discussion, which inevitably limits the potential for self-
determination (Kapp 2009).  In an era of ‘surveillance medicine’, whereby the onus is 
placed on individuals to mitigate and moderate risk behaviours in accordance with 
biomedical orthodoxy, the concept of patient autonomy creates an interesting paradox 
(Armstrong 1995; Armstrong 2014). It follows that patients can only be self-determining 
insofar as they exercise a form of ‘regulated autonomy’ – one that ensures their choices 
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and actions are in line with prescribed norms and practices to maximise health (Petersen 
1997).  
In view of this ambiguity, a more suitable term in this discussion is that of ‘patient 
empowerment’.  Patient empowerment is a relational construct which implies a 
redistribution of power between patients and providers, subject to continual negotiation 
(Roberts 2001); while patient autonomy is often construed in more atomistic terms 
(Donchin 1995). Empowerment implies a process of change whereby ‘those who have been 
denied the ability to make choices acquire such an ability’ (Kabeer 2002, p.437). Yet it is 
recognised that individual choices are always constrained and shaped by wider social and 
structural forces (Ibid.). 
1.8.2 The promise of e-STI testing services   
There is a normative assumption that e-sexual health services, including STI testing, will 
enhance patient choice and opportunities for self-management,  leading to improved 
health outcomes (Minichiello et al. 2013). 
e-STI testing services may enable users to take control of the testing process, providing 
more convenient testing pathways.  Samples are self-collected, often in the privacy of the 
user’s own home, and in a location and timing of their choosing. Contact with the service 
provider is maintained ‘at a distance’ via users’ personally controlled devices such as mobile 
phones and laptops. As in other health domains, this transferral of skills, roles and 
responsibilities may have significance for the reconfiguration of health care relations. 
Indeed, as a ‘faceless’ provider (Minichiello et al. 2013), the internet may shift the balance 
of power in favour of the user by limiting opportunities for providers to monitor, influence 
and ultimately judge patients’ sexual risk behaviours. In this way e-STI testing may bypass 
some aspects of stigma that are associated with face-to-face testing services.  
Yet, while e-STI testing services may hold considerable promise for patient empowerment, 
Lupton warns that the digital revolution in health is situated within ‘techno-utopian’ 
discourses which may in fact jar with patients’ actual experience (Lupton 2013). She posits 
that these technologies potentially infringe on patients’ power and agency, by permeating 
patients’ private spaces (e.g. their homes) and generating new mechanisms for medical 
surveillance. The responsibility implied by self-monitoring and management of health 
conditions may in fact represent an increasing burden for patients (Lupton 2013). 
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Furthermore, not all patients are at ease with new conceptualisations of patienthood, 
preferring a more passive role whereby decision-making can be deferred to a trusted 
professional (Henwood et al. 2003). 
1.9 e-STI testing - summary of evidence  
Publicly funded or subsidised e-STI testing services are available in a number of 
international settings, including Sweden, Australia, Canada and the USA. e-STI testing 
services are not homogenous (Turner et al. 2018). There is considerable variability in the 
functionality of websites, service components (including remote support), and level of 
integration with local services. Typically e-STI testing enables users to order a test kit from a 
virtual service (via a website or app), collect their own samples, post test samples to a 
laboratory, and be notified of their results by short message service (SMS) text message or 
telephone (Woodhall et al. 2012; Harding-Esch et al. 2016). Other versions may require 
users to order their self-sampling kits online, but collect test kits from a face-to-face setting 
such as a clinic or laboratory.    
In the UK, national guidelines recommend e-STI testing to expand routine testing for HIV in 
areas of high prevalence (National Institute for Health and Care Excellence 2016), as well as 
opportunistic screening for chlamydia among young adults (Public Health England 2015b). It 
is envisaged that e-STI testing can complement existing service provision, offering patients 
more choice. Moreover there is an assumption that e-STI testing can increase utilisation 
among individuals who do not use face-to-face STI testing services (Public Health England 
2015b).  
The international evidence base on e-STI testing services is scant. One randomised 
controlled trial in France has evaluated self-sampling for chlamydia accessed via the 
internet compared to chlamydia testing in face-to-face settings. It reports an increase in 
testing uptake (29.2% in the intervention group v 8.7% in the control group, RR 3.37, 95% CI 
3.05 – 3.74).  However, outcomes were assessed using different measures in the 
intervention and control groups, and there was low and differential follow up (47% follow 
up in the intervention group v. 30% follow up in the control group) (Kersaudy-Rahib et al. 
2017). 
Descriptive studies suggest that e-STI testing can attract high risk groups and yield high STI 
positivity. In the United States, Ladd and colleagues found that out of 205 rectal samples 
ordered and returned by women using the ‘iwantthekit’ website between January 2009 and 
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February 2011, 18.5% were positive for at least one STI (Ladd et al. 2014). The majority of 
women in the sample were single (91.2%), young (mean age 25.8 years) and of African-
American ethnicity (50.0%).  Half had never used condoms for rectal sex (48.7%).  A study 
with male users of the same website found that of 501 STI kits returned by men over the 
age of 14, between September 2006 and May 2009, 21% tested positive for chlamydia, 
gonorrhoea or trichomonas vaginalis (Chai et al. 2010).  The majority of users were young 
(median age 24.5 years), single (84%) and a high proportion were of black ethnicity (45%). 
While these studies are promising, sample sizes have been small and no comparison were 
made with users of face-to-face pathways.   
A recent observational study evaluated an online treatment service or eSexual Health Clinic 
(eSHC) in London. The eSHC pathway was offered to patients diagnosed with chlamydia in 
GUM clinics and to patients diagnosed via an e-STI testing service (Checkurself) (Estcourt et 
al. 2017). The eSHC pathway provided remote access and management of test results, a 
web-based risk assessment tool, and e-prescription for treatment collection at community 
pharmacies. In all, among those diagnosed via Checkurself, 89% were treated though a 
combination of remote and face-to-face care; and this is similar to the proportion of 
Checkurself users habitually treated in routine settings (~88%). 57% of Checkurself users 
were treated solely via the eSHC pathway, which included telephone support. These 
findings suggest that remote treatment pathways are feasible for users of e-STI testing 
services. However, a randomised study is required to generate conclusive evidence on the 
public health effectiveness of online treatment services (Estcourt et al. 2017). 
Evidence from routine surveillance data in England indicates that chlamydia testing uptake 
via internet-accessed pathways is much lower than face-to-face testing pathways, but that 
chlamydia test positivity (the proportion of tests that are positive) is comparable to other 
settings.  In 2016, 8% of chlamydia tests in England among 15-24 year olds were conducted 
via internet accessed pathways. Internet test positivity was 8.5% which is slightly lower 
than specialist GUM clinics (11.1%) but higher than GP settings (6.3%) (Public Health 
England 2017d).  
Between November 2015 and October 2017, 44,791 test kits were returned and tested by 
the national HIV self-sampling website (www.freetesting.hiv). The majority were from MSM 
(71%). Among this group, 31,734 kits were tested, of which 1.07% (340/31,734) were 
reactive. Although the service targets black African groups, only 7.25% (3,238/ 44,660) of 
tested kits were from this population, yielding a reactive rate of 1.76% (57/3,238). Just 
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under a third (29.9%) of those who returned kits had never tested for HIV previously. The 
service suffers from inefficiencies as 44.5% of test kits were not returned (Public Health 
England 2018b).  
Qualitative research, conducted with potential users of e-STI testing services suggests that 
e-STI testing might be acceptable to groups at risk of STIs including MSM and young adults, 
due to ease, convenience and enhanced privacy (Aicken et al. 2016; Hottes et al. 2012). 
Privacy, trust and credibility of websites or apps were highlighted as important 
considerations for service development. However, there is some uncertainty on whether e-
STI testing services would be acceptable to marginalised populations. In Scotland, Lorimer 
and McDaid (2013) found that young men from more deprived areas seemed more 
disconnected from digital technology and stated a preference for face-to-face services.  
Self-sampling diagnostic modalities for STIs not accessed by the internet have 
demonstrated an increase in testing uptake but they have yet to demonstrate a benefit in 
terms of cases detected and treated. A Cochrane review of home versus clinic specimen 
collection for chlamydia and gonorrhoea found inconclusive evidence for an effect on case 
management, defined as cases tested, diagnosed and treated (pooled risk ratio (RR) 0.88, 
95% CI 0.60-1.29) (Fajardo-Bernal et al. 2015). Moreover, home self-sampling yielded a 
lower proportion of positive tests than clinic sampling (pooled RR for positive test 
prevalence 0.72, CI 0.61, 0.86). Nevertheless 8 of 10 trials demonstrated an increase in 
testing uptake, although results were not pooled due to heterogeneity of effect sizes. Many 
studies had methodological limitations including high attrition (Ibid.). 
International guidelines recommend self-testing to expand screening of HIV (World Health 
Organisation 2016). Self-testing differs from self-sampling testing modalities as it enables a 
person to take a sample, perform a test and interpret the results without the need for a 
laboratory (Harding-Esch et al. 2016). A systematic review found that compared to facility-
based testing, HIV self-testing increases uptake among hard to reach and high risk 
populations, including male partners of female clients of ante-natal clinics and MSM 
(pooled RR 2.12, 1.51 to 2.98). Two studies assessed HIV positivity as a secondary outcome 
but both trials were two small to draw conclusive findings (Johnson et al. 2017).  
There is some limited emerging evidence on linkages to care following unsupervised HIV 
self-testing in community settings in sub-Saharan Africa (SSA). One observational study in 
Malawi found that 56% of clients who reported a positive result accessed confirmatory 
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testing and care, and this level of linkage was deemed acceptable for community based HIV 
testing in SSA (Choko et al. 2015). A cluster RCT in the same setting found that among 
adults offered self-testing for HIV, almost 3 times as many participants initiated ART when 
they were offered home care compared to facility care (RR, 2.94, 95%CI 2.10-4.12; 
P<0.001). However the proportions initiating ART were low overall, and the study was not 
powered to assess retention within ART programmes (MacPherson et al. 2014). Further 
evaluation of linkages to care, including adherence to ART, is required across diverse 
settings (Sharma et al. 2015). 
1.10 Chapter summary  
In this chapter, I presented an overview of the distribution of STIs in England and the UK, 
and I reviewed national STI testing guidelines and current testing coverage among key 
population groups. I outlined the promise of e-STI testing as a means to bypass the stigma 
and inconvenience that is associated with face-to-face STI testing services, and its potential 
to facilitate the normative goals of patient empowerment and patient-centred care. 
Nevertheless, while promising, I demonstrated the limited evidence base for the 
effectiveness of e-STI testing.  In the following chapter, I introduce the study context and 
the e-STI testing service – SH:24 - that I evaluated for this thesis.  
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Chapter 2: SH:24 e-STI testing and results 
service  
2.1 Intervention context 
The London boroughs of Lambeth and Southwark are characterised by particularly high levels 
of sexual ill health relative to the rest of London and the rest of England. This includes high 
rates of sexually transmitted infections (STIs), early pregnancy and abortion. In 2016, the 
diagnosis rate for new cases of HIV per 100,000 population (aged 15 years and over) was 
105.4 and 44.2 in Lambeth and Southwark respectively, compared to 27.6 per 100,000 
population in the London region as a whole. For all other STIs (excluding chlamydia in under 
25s) the diagnosis rates were 3,288 and 2,799 per 100,000 population (aged 15-64 years) in 
Lambeth and Southwark, compared to 1,547 in London and 795 in England (Public Health 
England).   
This epidemiological profile is partly explained by the socio-demographic composition of the 
boroughs, which includes high proportions of at-risk groups including young people, black 
and minority ethnic (BME) populations and men who have sex with men (MSM). At the same 
time, socio-economic factors such as high levels of deprivation are likely to play a 
contributory role (Lambeth Southwark Lewisham Councils 2014). 
In line with the national sexual health framework (United Kingdom Department of Health 
2013)(UK Department for Health 2013), preventative and curative sexual health services are 
currently provided by a range of providers, including genitourinary clinics (GUM), community 
based sexual and reproductive clinics, general practice (GP) surgeries as well as private 
providers such as Brook. While face-to-face sexual health services are considered to be high 
quality, these services are under increasing pressure to meet rising demand in a context of 
diminishing resources for sexual health (Robertson et al. 2017) . 
2.2 SH:24 – an e-STI testing and results service 
Sexual Health 24 (SH:24) is a community interest company (CIC), set up in 2013 with 
funding from Guys and St Thomas’ Charity for the purpose of developing and establishing 
an online sexual health service in Lambeth and Southwark (www.sh24.org.uk). The 
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overarching aim of the service is to improve sexual health outcomes in the population, 
while generating efficiency savings (SH:24 2013b).  
SH:24 adopts a ‘user-led’, agile, approach to service development. This is based on build-
test-learn philosophy. In the discovery phase a number of product prototypes were 
developed based on consultation with potential service users in Lambeth and Southwark. 
Each prototype underwent extensive testing and adaptation to ensure its acceptability with 
providers and users.  
SH:24 completed its first ‘minimal viable product’ (MvP) in November 2014. MvP1 is an 
internet-accessed STI testing and results service (e-STI testing). The version that I evaluated 
offered free postal self-sampling test kits for chlamydia, gonorrhoea, HIV and syphilis.  
Users who ordered a test kit from SH:24, were required to complete a short order form 
online. Those reporting STI symptoms were advised via a pop up message to visit their local 
clinic for immediate treatment. Those reporting complex needs such as depression, drug 
and alcohol dependency, or exploitative sexual partnerships were telephoned by a clinician 
and referred to relevant clinical services.  Users could continue to use the online service if 
they wished.   
All test kits contained a lancet and collection tube to obtain a blood sample for serological 
testing for syphilis and HIV. For chlamydia and gonorrhoea, women were sent vaginal 
swabs and men were sent a container for first catch urine samples. Test kits for MSM also 
contained swabs to take pharyngeal and rectal samples.  
The test kits included pictorial leaflets with guidance on how to collect the specimens. A 
video demonstrating blood sample collection was available on YouTube and could be 
accessed via the SH:24 website. Users were encouraged to text or phone the SH:24 team 
with any questions or concerns. Non-returners were sent reminders via text message and 
resent test kits if required, as per SH:24’s protocols.  
Chlamydia, gonorrhoea and syphilis test results were delivered by text message.  
Participants with reactive results for syphilis or positive results for chlamydia and 
gonorrhoea were signposted to local clinics for confirmatory testing and treatment as 
necessary. Reactive results for HIV were communicated by phone by a clinician. The SH:24 
website also provided health education information on STIs and safer sex practices. 
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Since the completion of the first minimal viable product, SH:24 has continued to develop 
and expand, gradually adding new products and increasing functionality to the website, 
including telephone support, postal treatment for chlamydia and contraceptive services.  
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Figure 2: SH:24 user journey (SH:24 2013a) 
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2.3  SH:24 Evaluation  
As an untested intervention, SH:24 has implications for the commissioning of sexual health 
services not only in London but also nationally. Moreover, given the limited evaluative work 
in the field of online services for sexual health more generally, the SH:24 evaluation is likely 
to make an important contribution to the international evidence base. 
The theory of change for the e-STI testing component of SH:24, developed by Baraitser and 
colleagues from Kings College London (Baraitser et al. 2015), draws on the original funding 
proposal and articulates three anticipated outcomes at the system level. These are: 
reduced STI transmission, more cost effective sexual health services and changes in 
patterns of service use.  
Increased access to STI testing is deemed to be a key intermediary outcome on the pathway 
to reducing STI transmission rates in the population.  It is hypothesised that the provision of 
e-STI testing alongside usual face-to-face care will increase uptake of STI testing services, 
leading to increased diagnoses and treatment of STIs, thus interrupting disease 
transmission pathways. It is recognised that the contribution of e-STI testing to population 
health is contingent on the epidemiological profile of the additional users of STI testing 
services.   
Figure 3. Theory of change for SH:24 (Baraitser et al. 2015, Figure 1) 
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Clinical effectiveness of this service is therefore determined by two interrelated outcomes: 
1) uptake of STI testing services and 2) diagnoses and treatment of STIs. A simplified logic 
model outlining this causal pathway is presented in figure 4.   
 
2.4 Thesis objectives  
In line with the objectives of SH:24 outlined in the original funding proposal, my thesis aims 
to evaluate the clinical effectiveness of SH:24 via a randomised controlled trial (RCT). This is 
defined as uptake of STI testing, STI diagnoses and STI treatment.  National guidelines 
recommend e-STI testing as a means to increase testing uptake among those who do not 
attend face-to-face services, and I therefore conduct secondary analyses to determine if 
SH:24 increases testing uptake among first-time testers. 
  
Figure 4. Simplified logic model – SH:24 
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My specific objectives are as follows: 
1) To determine the effect of SH:24 on STI testing uptake, cases diagnosed and 
treated, when delivered alongside standard care; 
2)  To determine the effect of SH:24 on STI testing uptake among those who have 
never previously tested for STIs, when delivered alongside usual care. 
The following chapter outlines my theoretical framework for this evaluative work. The 
SH:24 evaluation adopts a flexible research philosophy to allow for a range of 
epistemological perspectives.  I draw on a critical realist perspective to theorise the causal 
mechanisms that may underpin the intervention, and in line with this perspective, I 
consider ‘contextual contingencies’ that may interact with these causal mechanisms 
(Fletcher et al. 2016). Further, I use the ‘candidacy’ framework to conceptualise access to 
STI testing services (Dixon-Woods et al. 2006). While it was beyond the scope of the thesis 
to test this model empirically, I utilise the candidacy framework to situate my evaluation 
findings.  
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Chapter 3: Theoretical Framework 
3.1 Chapter overview 
In this chapter, I review theory driven approaches to evaluation, and the challenges of 
applying these approaches to the evaluation of complex health interventions. I outline the 
theoretical premise underpinning this thesis, and I apply the ‘candidacy’ model to theorise 
how an e–STI testing service (SH:24) may improve access to STI testing in a complex service 
delivery system.  
3.2 Theory driven approaches to evaluation   
Theory-driven approaches to programme evaluation have emerged as a response to the so-
called ‘black-box’, method-led, evaluations which historically dominated the field of 
evaluation science (Scriven 1994). Early investigators, such as Campbell, advocated the co-
option of experimental methodologies from the natural sciences to assess the causal 
effects of large public programmes and policies in the United States (Campbell 1969). 
Importance was placed on achieving internal validity at the expense of understanding the 
inner workings of programmes and the underlying processes that trigger social change 
(Scriven 1994; Shadish, Cook & Leviton 1991; Chen & Rossi 1987). 
Prominent critics of this approach, including Cronbach (1980) and later Weiss (1972),  Chen 
and Rossi (1987), Pawson and Tilley (1997), have argued that aggregate measures of effect 
have limited utility for policy-making if evaluators fail to explain ‘why…for whom, and in 
what circumstances’ (Pawson & Tilley 1997, p.xvi) a programme may work both within and 
beyond its original social setting. Indeed, after the initial enthusiasm for large-scale 
experiments, policy makers in the United States became increasingly discontent with an 
evolving portfolio of evaluative research, characterised by inconclusive and inconsistent 
findings (Pawson & Tilley 1997). Crucially, outcome-focussed evaluations failed to 
illuminate whether programme failure could be attributed to poor implementation or poor 
programme design (Lipsey & Pollard 1989).  
To counter this problem, evaluation science took a methodological turn towards ‘theory-
driven’ or ‘theory-based’ approaches (Shadish, Cook & Leviton 1991; Chen & Rossi 1987; 
Weiss 1995).  This perspective seeks to determine not only whether a programme works, 
but also to understand ‘the transformational relations between treatment and outcomes, 
as well as contextual factors under which the transformation processes occur’ (Chen & 
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Rossi 1989, p.300). Evaluators may draw on varied sources to develop hypotheses for how 
social transformation might occur, including formal theories from the social sciences, as 
well as ‘professional logic’ arising from stakeholder expertise and perspectives (Weiss 
1997b).  The resultant overarching ‘programme theory’ is typically articulated via schematic 
diagrams such a logic models, which detail the sequential and recursive causal links 
between programme components, hypothesised intermediary phases, and anticipated 
outcomes (Rogers 2008; Coryn et al. 2010). These theoretical assumptions can then be 
subject to empirical testing and exploration (Kazi 2003) .  
Theory-driven approaches (TDA) may allow for greater transparency in programme design 
and evaluation as stakeholders are forced to make explicit their assumptions from the 
outset, which can then be subject to interrogation and adjustment (Van Belle et al. 2010).  
Moreover, proponents argue that TDA offers improved ‘explanatory power’ (Weiss 1997a), 
providing a conceptual framework within which findings can be situated and interpreted 
‘beyond the specific operations and idiosyncrasies’ of each evaluation setting (Lipsey & 
Pollard 1989, p.317).  TDA therefore attempts to offer some assessment of the external 
validity of evaluation results in a way that the early method-led evaluations did not (Scriven 
1994). 
3.3 Theory driven approaches and complex health interventions 
3.3.1 The Medical Research Council guidance   
In principle, the Medical Research Council in the United Kingdom endorses a theoretical 
perspective in the development and evaluation of complex health interventions (United 
Kingdom Medical Research Council 2006). Complex interventions have proliferated in the 
ambit of public health. This development is indicative of an increasingly broad 
conceptualisation of population health as determined by the interplay of biological, social 
and structural factors (Krieger 2001; Cohn et al. 2013). 
Defined as ‘built up from a number of components, which may act both independently and 
interdependently’ (United Kingdom Medical Research Council 2000, p2), complex 
interventions inherently pose greater methodological challenges than traditional 
evaluations of drug interventions. This is due to difficultly in identifying the ‘active 
ingredients’ of multi-component interventions and gaining an appreciation for how they 
may interact (United Kingdom Medical Research Council 2000); and the challenge in 
understanding how local contextual conditions may shape outcomes via intricate and 
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lengthy causal pathways (Bonell et al. 2012; United Kingdom Medical Research Council 
2006).   
The MRC framework underlines the importance of developing a ‘theoretical understanding 
of the likely process of change’ at the development stage of an intervention (United 
Kingdom Medical Research Council 2006, p.9). However it fails to offer guidance on how 
specific theory-driven approaches can be integrated within the complete cycle of 
intervention design, implementation and evaluation (De Silva et al. 2014; Anderson 2008). 
Bonell and colleagues (2012, p.2300) posit that this has resulted in ‘an evidence base that is 
dominated by high quality RCTs of poorly theorised interventions’, whose ‘effects are 
poorly understood’ thus limiting their potential for replication. Yet this is perhaps not 
surprising given that the application of theory-driven approaches both within public health 
and other applied settings such as education and social care is beset with challenges (Weiss 
1995). I discuss each of these challenges below.  
3.3.2 What constitutes theory in a theory driven approach? 
There is a lack of consensus on what constitutes ‘theory’ in a theory driven approach and 
how this theory should be generated (Weiss 1997a; Moore & Evans 2017).  In the health 
literature, there are two dominant frameworks (Blamey & Mackenzie 2007). The first is 
Theory of Change (ToC), which is a flexible framework that is not wedded to a particular 
epistemological or ontological perspective (De Silva et al. 2014; Weiss 1997b); the second is 
the realist (or realistic) approach, which is embedded within a critical realist paradigm 
(Pawson & Tilley 1997).  
Theory of Change can encompass two types of theory. These are implementation theory 
and programme theory (Weiss 2000) (also referred to by Chen (1989) as ‘normative theory’ 
and ‘causal theory’ respectively).  Confusingly, implementation theory is not a theory in any 
formal sense, i.e. a set of ‘general principles that provide explanations for empirical 
phenomena’ (Hammersley 1995, p.56). Instead, it is a descriptive and systematic account of 
the activities and inputs that comprise an intervention. It illustrates the relationship 
between intervention components and it specifies how planned activities should be 
executed to achieve desired outcomes. As Weiss (1997b) explains: 
The theoretical assumption it tests is that if the program is conducted as planned, with 
sufficient quality, intensity, and fidelity to plan, the desired results will be forthcoming. 
(p.46) 
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Programme theory, on the other hand, seeks to offer an explanatory account of how and 
why an intervention works (Astbury & Leeuw 2010). Importantly, it articulates the 
hypothesised mechanisms of change underlying the intervention. Weiss (1997b) forwards: 
An evaluation that attempts to track the theoretical underpinnings of the program has 
to devise ways to define and measure the psychological, economic, sociological, 
organisational, or other processes that intervene between exposure to the programme 
and participant outcomes. (p.48) 
Evaluators have drawn upon social-cognitive theories (such as the theory of planned 
behaviour), and other formal theories from the social sciences, to inform the ‘programme 
theory’ component of theory of change evaluations (Weiss 1997b; De Silva et al. 2014). Yet 
many worked examples still offer pragmatic rather than theoretical insights into change 
processes (Fletcher et al. 2016; Blamey & Mackenzie 2007).  Indeed, theory of change 
methodologies have evolved with a focus on community development and a commitment 
to participatory approaches and stakeholder ownership (for example the Aspen Institute 
Roundtable on Community Change). Emphasis is placed on garnering the perspectives and 
expertise of local actors (including beneficiaries, programme implementers and community 
leaders), to determine appropriate outcomes, map causal pathways (including possible 
unintended effects), and agree required resources (De Silva et al. 2014; Connell & Kubisch 
1998). 
While important, critics argue that this participatory, community-driven process should not 
be at the expense of generating ‘good theory’ (Weiss 1995): one that goes beyond the 
descriptive elements of an intervention, to conceptualise the underlying mechanisms on 
which the intervention rests, and how these are shaped by context (Fletcher et al. 2016). To 
achieve this, evaluators are advised to draw upon theoretical insights from the social 
sciences (particularly psychology and sociology), research evidence, as well as their own 
‘logical reasoning’ (Weiss 1997b, p.51; Lipsey & Pollard 1989).   
The second strand of theory driven approaches in the evaluation of complex health 
interventions are realist evaluations. First proposed by sociologists Pawson and Tilley 
(1997), realist evaluations stem from a critical realist philosophy. Critical realism adopts a 
stratified view of social reality, distinguishing between the realms of the real, the actual and 
the empirical (Bhaskar 2008). This is in contrast to the ‘flat’ ontologies of other research 
philosophies (Sayer 2010, p.12). For example a positivist ontology only pertains to the 
empirical i.e. reality is confined to that which can be observed and experienced.   
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The stratified ontology forwarded by critical realism is as follows: the real pertains to 
physical or social objects, ‘their structures and powers’, that exist independently of our 
experience and understanding of them (Sayer 2010, p.11); the actual are the ‘patterns of 
events’ that can be triggered by the powers or mechanisms within the real; and the 
empirical refers to the experience of these events (Bhaskar 2008, p.37; Sayer 2010).  
As Bonell and colleagues explain (2016):  
…realists believe they can identify objective truths describing the actual realm and can uncover 
the true causal mechanisms of the real realm based upon data from the empirical realm. (p.2)  
Mechanisms, in a realist sense, are therefore ‘causal powers’ that ‘lie behind’ an 
intervention (Pawson & Tilley 1997) – not to be equated with intervention inputs or 
activities.  
Mechanisms are the agents of change. They describe how the resources embedded in a 
programme influence the reasoning and ultimately behaviour of programme subjects. (Pawson 
2013, p.115) 
Scientific realism holds that mechanisms are not external factors but latent powers and 
capabilities, which are a function of the interaction between intervention resources and 
responses of participants. (Van Belle et al. 2016, p.3) 
Further, in a realist evaluation, context holds importance beyond the mechanics of 
intervention delivery. Context is intrinsic to the causal process itself. Context interacts with 
mechanisms to generate outcomes, and these processes will vary across social settings 
(Sayer 2010; Pawson & Tilley 1997). The realist formula underpinning social change is 
therefore summarised as (Pawson & Tilley 1997, p.xv): 
context + mechanism = outcome 
Realists prioritise developing and testing ‘middle range’ theories related to hypothesised 
context-mechanism-outcome configurations. Put simply, these are ‘propositions about how 
mechanisms are fired in contexts to produce outcomes’ (Pawson & Tilley 1997, p.85).  
Similar to the articulation of programme theory by Weiss (2000), hypotheses can be 
derived from prior evidence and formal theories from the social sciences, which are then 
subject to empirical testing and refinement (Kazi 2003).   
There is great divergence in the way theory of change and realist approaches are applied in 
practice (Coryn et al. 2010; Marchal et al. 2012). In the case of complex health 
interventions, the principles of either approach are often not applied systematically (De 
Silva et al. 2014; Marchal et al. 2012). Theory of change methodologists appear to have 
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given greater attention to the development of operational principles rather than to 
theoretical ones (for example there are a plethora of field manuals giving guidance on 
conducting ToC in applied settings (Vogel 2012); and this may explain the theory deficit in 
many evaluations.  Realist evaluation, on the other hand, is based on more clearly defined 
ontological and theoretical propositions. Yet its application is still in a nascent stage in 
health sciences, and some applied researchers have struggled with the interpretation of the 
critical realist ontology (Porter 2015; Marchal et al. 2012).  
3.3.3 Complexity in complex health interventions 
A second, but related challenge, in the application of theoretical-driven approaches is the 
debate on what is meant by complexity in complex health interventions. Commentators 
have critiqued the MRC for ‘appropriating’ complexity science in its guidelines for the 
evaluation of complex health interventions (Cohn et al. 2013). They argue that an important 
distinction exists between interventions which are ‘complicated’ -  those comprised of 
multiple interrelated or interacting components – and interventions (simple or 
complicated) that are introduced into ‘complex systems’ (Shiell, Hawe & Gold 2008; 
Glouberman & Zimmerman 2002). 
For complexity theorists, it is preferable to think of complexity as a ‘property of a system 
not an intervention’ (Shiell, Hawe & Gold 2008, p.1281). A system may refer to a single 
entity or combination of entities which often include organisations, schools, communities 
and service delivery networks (Foster-Fishman Pennie, Nowell & Yang 2007). System 
boundaries can be fluid, defined by the nature of the problem to be addressed: 
Within the context of systems change, what we refer to as ‘the system’ is the set of actors, 
activities and settings that are directly or indirectly perceived to have influence in or be affected 
by a given problem situation. (Ibid., p. 198)  
Complex systems are characterised by behaviours and processes that are dynamic, adaptive 
and non-linear (Rickles, Hawe & Shiell 2007). Hawe, Shiell & Riley (2009) forward that 
interventions introduced into these systems are best understood as ‘events in systems’. The 
success of an intervention is contingent not on the discrete workings of its constituent 
parts, but on how the intervention disrupts, and potentially transforms, pertinent features 
of the system (Moore & Evans 2017; Hawe, Shiell & Riley 2009).  As a consequence, the 
focus of the evaluation shifts, as Rutter and colleagues explain: 
Instead of asking whether an intervention works to fix a problem, researchers should aim to 
identify if and how it contributes to reshaping a system in favourable ways. (2017, p.2602) 
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This thinking challenges evaluators to consider causal processes that might previously have 
been obscured by more simplistic causal models; and to consider intervention effects at the 
system level rather than solely at the individual level (Rutter et al. 2017; Shiell, Hawe & 
Gold 2008).  
Indeed, important features of complex systems are their ‘emergent properties’ (Rickles, 
Hawe & Shiell 2007) – defined as ‘a property of a system that is not reducible to, nor readily 
predictable from the properties of individual system components’ (Halley & Winkler 2008, 
p.10). Emergent properties pertinent to the production of health might comprise structural 
characteristics such as community empowerment or social exclusion (Shiell, Hawe & Gold 
2008). Moreover, population health is conceived as an emergent property of multiple 
complex systems. For example Rutter and colleagues (2017, p.2602) cite the changing 
prevalence of obesity within a population as an, ‘emergent property of the food, 
employment, transport, economic, and other systems that shape the energy intake and 
expenditure of individuals’.  
Critical realists also recognise the emergent properties of natural and social phenomena 
(Sayer, 2010).  Certainly, the realist evaluation framework is well placed to incorporate a 
complex systems perspective (Fletcher et al. 2016; Byrne 2013). Pawson and Tilley (1997, 
p.70) conceive interventions to be embedded within dynamic social systems, whose 
functioning is contingent on the way ‘pre-existing structures’ within these systems ‘enable’ 
or ‘disable’ the intended mechanism of change. Hence, both frameworks necessitate the 
foregrounding of context both in the theorisation, and in the applied understanding, of 
change processes.  
While this synergy is conceptually appealing, Cohn and colleagues highlight that the 
challenge for evaluators interested in complexity is, ‘how to go about studying complexity 
without fully unravelling it’ (Cohn et al. 2013, p.42). Chen (2016) cautions that excessive 
complexity – innumerable causal pathways, feedback loops and interactions – runs the risk 
of rendering evaluation findings uninterpretable. Weiss (2000), while not addressing 
complexity theorists directly, advises that all theory-driven evaluations focus on a few key 
theoretical propositions, rather than trying to tackle a programme’s theoretical complexity 
in its entirety. Similarly Hawe (2015), a key proponent of complexity theory in population 
health, underlines the importance of understanding the core ‘functions’ of intervention 
components in generating change, as it is these essential insights that enable the 
replication of programmes across contexts. As Hawe and colleagues explain (2004): 
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Rather than defining the components of the intervention as standard—for example, the 
information kit, the counselling intervention, the workshops—what should be defined as 
standard are the steps in the change process that the elements are purporting to facilitate or the 
key functions that they are meant to have. For example, ‘workshops for general practitioners’ are 
better regarded as mechanisms to engage general practitioners in organisational change or train 
them in a particular skill. (p.1562) 
…The issue is to allow the form to be adapted while standardising the process and function. 
(p.1562) 
3.3.4 Epistemological and ontological perspectives in the evaluation of complex 
health interventions 
Finally, applying a theory-driven approach presents challenges due to the contested 
epistemological and ontological standpoints among the evaluation community. The place of 
the randomised controlled trial (RCT) in evaluative research is a particular source of 
contention. While the MRC framework (United Kingdom Medical Research Council 2000) 
champions RCTs as the most rigorous and valid method for evaluating complex health 
interventions, this is countered by some evaluation theorists and practitioners on 
epistemological and methodological grounds.  
First, RCTs are assumed to be intrinsically wedded to a positivist epistemology, and 
therefore incompatible with alternative research philosophies in evaluative research, 
including critical realism (Van Belle et al. 2016; Pawson & Tilley 1997). Yet as Bonell and 
colleagues remind us, the RCT is a method used to capture an objective reality (2013), and 
randomisation a procedure that allows ‘minimally biased’ comparisons between groups 
(Bonell et al. 2012, p.2300). The method itself does not preclude researchers applying a 
number of epistemological and ontological framings to the data, including a critical realist 
perspective. 
When we do RCTs, we hold the same realist epistemological and ontological assumptions that we 
hold when we undertake non-randomised evaluations or exploratory qualitative research. Our 
methods don’t determine our assumptions, we as researchers determine our understanding of 
the data deriving from these methods. (Bonell et al. 2013, p.81) 
A second related charge is that RCTs are overly reductionist in their application. Critics 
question the appropriateness of trials that attempt to ‘isolate’ the effects of an intervention 
from the social context within which it is embedded, thus negating the influence of 
contextual factors on outcomes (Marchal et al. 2013; Cohn et al. 2013; Pawson & Tilley 
1997).  Bonell, Bennett and Oakley (2003) demonstrate that this reasoning is conceptually 
flawed. In relation to experimental designs in sexual health, they forward:  
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The aim is to see how the intervention interacts with and contributes to the broader picture… 
rather than pretending this picture does not exist. Experimental evaluations seek to examine the 
‘added value’ that an intervention brings to sexual health outcomes across a population of 
individuals, rather than seeking to suggest that an intervention ‘causes’ a sexual health outcome 
in any one individual. (p.9)  
The argument thus follows that RCTs are highly appropriate for evaluations of complex 
interventions, provided that they are situated within a comprehensive theoretical 
framework and additional research methods are used to shed light on hypothesised change 
processes (Bonell, 2012).  While RCTs yield an overall aggregate effect of the ‘added value’ 
of an intervention embedded within a complex social system, this can be complemented by 
further statistical analyses. For example, mediation analyses can explore hypothesised 
causal pathways while moderation analyses may be used to understand how intervention 
effects are modified by ‘contextual contingencies’ (Fletcher et al. 2016, p.296). Crucially, 
qualitative methodologies can facilitate the development of initial theoretical propositions 
and explore complex change processes with greater depth and flexibility, complementing or 
indeed challenging findings derived from quantitative data (Oakley et al. 2006; Jamal et al. 
2015; United Kingdom Medical Research Council 2015). 
Combining and integrating RCT and qualitative evidence, is both theoretically and 
analytically challenging (Lewin, Glenton & Oxman 2009; United Kingdom Medical Research 
Council 2015). Some argue that an inherent ontological tension exists in trying to combine 
evidence generated from apparent positivist and interpretive perspectives (Blackwood, 
O'Halloran & Porter 2010; Munro & Bloor 2010). Others highlight tensions of a political 
nature as qualitative social science evidence continues to be devalued within evidence-
based public health (Daniels et al. 2016), and therefore the inclusion of qualitative inquiry 
within multi-disciplinary projects can be somewhat superficial and simplistic (Béhague, 
Gonçalves & Victora 2008).  
Proponents of realist RCTs suggest that a critical realist framework facilitates the 
combination of RCT evidence and evidence from qualitative inquiry within a cohesive 
philosophical framing (Blackwood, O'Halloran & Porter 2010; Bonell et al. 2016); and 
empirical work is underway to further test this proposition (Jamal et al. 2015).  It is worth 
noting however, that Pawson and Tilley (1997), the originators of realist evaluation, take a 
somewhat instrumental view of qualitative methodologies, positing that the scope of 
qualitative inquiry should be limited to testing a priori theories with evaluation 
stakeholders and ‘subjects’ of social programmes: 
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 … the researcher’s theory is the subject matter of the interview and the interviewee is there to 
confirm or falsify and, above all, refine that theory. (p.159) 
This overlooks the value of capturing emic beliefs, perspectives and experiences within 
specific contexts and seems to disregard the potential of inductive research strategies to 
inform formative hypothesis-generation. 
3.4 Theoretical premise of thesis 
A critical realist perspective provides a useful philosophical and methodological framing for 
complex health interventions. It is also compatible with key tenets of complex systems 
theory. While it was beyond the scope of this thesis to conduct a realist evaluation, I draw 
on concepts from this perspective in developing an explanatory framework for how an e-STI 
testing service will increase access to STI testing within a complex service delivery system. 
In subsequent chapters, I situate the evaluation findings within this framework.   
To develop this framework, I drew on the candidacy model to conceptualise access to STI 
testing services, alongside research evidence and the initial theory of change for the 
intervention. I apply a realist understanding of causal mechanisms that may underpin the 
intervention; and I consider contextual contingencies that may interact with these causal 
mechanisms. I identify and discuss change processes that may be dynamic, adaptive and 
recursive.  
3.5 e-STI testing to improve access to STI testing services – an 
explanatory framework 
3.5.1 Conceptualising access to health  
Within health services research, access to health care is conceptualised as a function of the 
interplay between the needs, preferences and resources of the population on the one 
hand, and the characteristics of the health system on the other (Penchansky & Thomas 
1981b; Aday & Andersen 1974). It follows that a closer alignment between these sets of 
characteristics will result in desirable outcomes such as improved health status and 
increased patient satisfaction (Penchansky & Thomas 1981a; Andersen et al. 1983). While it 
is recognised that access is a multifaceted and complex construct, most frameworks rely on 
utilisation as a proxy indicator for access (Levesque, Harris & Russell 2013; Goddard & 
Smith 2001).   
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Andersen’s behavioural model of health services’ use – one of the most cited in the health 
services literature - is commonly used to predict or explain health care utilisation (Andersen 
1995; Ricketts & Goldsmith 2005). The model accounts for both supply and demand side 
determinants underpinning utilisation, including individual socio-demographic 
characteristics and health seeking beliefs (so called ‘predisposing characteristics’). 
Importantly it also considers the wider social and cultural context in which these beliefs are 
embedded, as well as the ‘enabling resources’ at the level of the community and family 
which can facilitate or hinder health seeking behaviours (Figure 5).  
Source: (Aday & Andersen 1974, p.212) 
Dixon Woods and colleagues (2006) posit that a narrow focus on utilisation – or receipt of 
health care - obscures the complex interactions between individuals and providers that 
underpin how people seek out and receive care within formal health systems. Rather than 
Figure 5. Aday and Andersen’s framework for the study of access 
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viewing access solely as a technical fit between supply and demand side factors, they argue 
that access is best understood through the lens of candidacy.   
The candidacy lens places emphasis on how the use of health care is a dynamic process of 
negotiation and social interaction between patients and professionals. Access is not viewed 
as a single ‘event’, but rather a continual process, from the initial recognition of candidacy 
to the subsequent navigation and negotiation of services (Mackenzie et al. 2013). These 
processes can expose vulnerabilities in health-seeking, which in turn generate barriers to 
care: 
…. candidacy describes the ways in which people’s eligibility for medical attention and 
intervention  is a dynamic and contingent process, constantly being defined and redefined 
through interactions between individuals and professionals, including how ‘cases’ are 
constructed.  Accomplishing access to healthcare requires considerable work on the part of users, 
and the amount, difficulty, and complexity of that work may operate as barriers to receipt of 
care.  (2006:7) 
An understanding of candidacy, in conjunction with utilisation evidence, may offer a deeper 
appreciation of access to health care within complex health systems. In particular, this lens 
can expose inequities that arise along care-seeking trajectories, which may be obscured by 
utilisation measures alone (Macdonald et al. 2016; Dixon-Woods et al. 2006).  
3.5.2 Applying the candidacy lens to a digital service environment.  
Candidacy has been applied to understand health-seeking and use of care in a number of 
arenas including sexual health (Normansell, Drennan & Oakeshott 2016).  Below, I adapt 
the candidacy model to theorise how an e-STI testing service may increase claims to 
candidacy in a complex sexual health delivery system. I explain each step of this framework, 
drawing on seminal publications by Dixon-Woods and colleagues (Dixon-Woods et al. 2005) 
and more recent work by Macdonald and colleagues (Macdonald et al. 2016) and 
Mackenzie and colleagues (Mackenzie et al. 2013), as well as the initial theory of change 
and wider literature. I present propositions for how e-STI testing may prompt increased 
recognition of candidacy, and enable smoother negotiations of STI testing trajectories, 
leading to increased utilisation of STI testing services.  
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Figure 6. The candidacy framework (adapted from Macdonald et al. (2016), Figure 1)  
 
Recognition of candidacy 
This is the process through which individuals recognise that they have a legitimate claim to 
health services. This process is patterned by psychological, social and cultural factors as well 
as lay health beliefs, including perceived need for care. In the ambit of sexual health, 
perceived need for care is mediated by individuals’ understanding and awareness of past 
risk behaviour and potential exposure to STIs, particularly in the absence of symptoms.  
Moreover, perception of risk intersects with social and cultural norms around appropriate 
help-seeking (Dixon-Woods et al. 2005).  As discussed in chapter one, young women may 
not seek sexual health care in order to safeguard their  social identities as ‘responsible 
moral agents’ (Balfe et al. 2010a, p138); while young men may perceive help-seeking to be 
incompatible with traditional masculine traits of strength and invulnerability (Shoveller et 
al. 2010; Courtenay 2000).   
Recognition of candidacy is also influenced by perceptions on the availability, 
appropriateness, and quality of care, including whether health-seeking behaviour will elicit 
judgement from health professionals (Dixon-Woods et al. 2005). The theory of change for 
SH:24 suggested that e-STI testing pathways may bypass the stigma associated with the 
face-to-face clinical encounter, while offering more choice and convenience.  Importantly, 
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this enhanced choice is mediated by biomedical factors. The primary beneficiaries of e-STI 
testing are asymptomatic individuals, for whom remote testing is appropriate. Symptomatic 
users who attempt to order a test kit via SH:24 are signposted to face-to-face facilities for 
clinical assessment.  Nevertheless, the theory of change for SH:24 proposes that these 
individuals may accrue indirect benefits if asymptomatic patients seeking routine testing, 
are channelled effectively to online pathways, thus increasing clinic capacity for complex 
care (Baraitser et al. 2015).   
I propose that the offer and availability of e-STI testing will trigger increased recognition of 
candidacy in the population, as e-STI testing pathways will be perceived to be better 
aligned with the population’s health-seeking preferences. I consider this increased 
recognition of candidacy to be the principal mechanism that will be triggered by the 
intervention, which in turn will prompt health-seeking actions. In line with realist 
approaches to evaluation, the way this mechanism operates is likely to vary across social 
groups and social contexts.   
Formative research with young people in the UK  has indicated that remote STI testing 
pathways may prove acceptable (thereby influencing recognition of candidacy) as they 
enable young people to avoid the stigma and embarrassment of attending clinical services 
(Aicken et al. 2016). Qualitative studies in Canada also found that MSM were attracted by 
the potential anonymity and agency afforded by remote pathways (Hottes et al. 2012). 
Indeed the avoidance of a face-to-face encounter ensures that patients’ social identities 
remain untainted by possible moral judgements from health care professionals or other 
members of the public (Datta et al. 2018; Balfe et al. 2010a) . 
Yet research with prospective black African users of self-sampling kits for HIV in the UK, 
found that rather than alleviating stigma, receiving test kits at home could generate  
embarrassment due to limited privacy (Seguin et al. 2018). This concern is shared by some 
young people who live with their parents or in shared housing (Lorimer & McDaid 2013). 
Some black African participants also highlighted that the use of self-sampling kits would 
require negotiation with their partners (Seguin et al. 2018). Levels of health literacy and 
competency in the use of new technologies are also likely to influence the acceptability of  
e-STI testing pathways  across all social groups (Baraitser et al. 2015).  
The health-seeking actions that are triggered by the introduction of e-STI testing into a 
complex service delivery system will therefore depend on how e-STI testing is perceived to 
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alleviate the diverse barriers to care experienced by different socio-demographic groups.  
Moreover, the translation of these health-seeking actions into concrete health benefits is 
contingent on how individuals proceed to navigate digital and face-to-face testing 
pathways.  
Navigation and permeability of services 
The candidacy model describes discrete phases in the navigation of services (Figure 6). Yet  
in practice they may overlap (Macdonald et al. 2016).  Navigation of services refers to the 
routes taken from the recognition of candidacy to gaining entry to services. Navigation is 
contingent on competencies and resources, including knowledge, financial resources (such 
as transport) and social support (Dixon-Woods et al. 2005). 
Permeability of services refers to the ease with which people can use services.  ‘Porous’ 
services require less qualifications of candidacy, less negotiation and are more culturally 
aligned with patients’ expectations (ibid.).  
e-STI testing pathways may be easier to navigate and more ‘porous’, requiring less time and 
resources than face-to-face pathways. Crucially, as described in the theory of change, the 
online pathway avoids the requirement of a physical visit to a health service in order to 
complete an STI test. Further, the e-STI testing service aims to be user led and to promote 
user autonomy (Baraitser et al. 2015). e-STI testing may therefore be more culturally 
aligned to some groups, for example those groups with a preference for self-management.  
Interactions with health services 
This refers to the work a patient must do to assert their claims to candidacy when 
interacting with health professionals (Dixon-Woods et al. 2005).  
e-STI testing is based on remote interaction with health professionals via text message and 
telephone, which avoids the traditional social interaction of the clinical encounter. For 
some users, this ‘remote encounter’ may be less stigmatising and more empowering, 
allowing for a smoother negotiation thus contributing to the reconfiguration of patient-
provider relations.   
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Adjudications and resistance 
Adjudications are the judgements made by professionals on the continued candidacy of 
individuals including follow up and referrals. These adjudications may be subsequently 
refused and resisted by patients (Dixon-Woods et al. 2005).  
e-STI testing pathways are designed to be user-led with individuals directing the candidacy 
process. However, e-STI testing modalities are often integrated with face-to-face care, 
which may introduce opportunities for professional adjudication.  As discussed in chapter 2, 
SH:24’s care pathways involve two principal referrals points. Firstly, users with complex 
needs and symptoms are referred to clinic during the initial screening process, and secondly 
at the time of the evaluation, users who completed an STI test via SH:24 were referred to 
clinic at the point of diagnosis. These adjudications may have implications for the continued 
candidacy of users, and could be subject to resistance.    
Operating conditions and the local production of candidacy 
These are the influences on future service use including availability of local resources as 
well as the emergent relationships between professionals and patients. This shapes the 
future recognition of candidacy and the ability of individuals to claim their candidacy. Both 
professional and lay interpretations of candidacy are contingent on broader social, cultural 
and political factors, which are also in flux and subject to change (Dixon-Woods et al. 2006).  
The change processes prompted by the introduction of e-STI testing within a complex 
service delivery system are likely to be dynamic and adaptive.  It is envisaged that e-STI 
testing will facilitate patient empowerment and lead to a reconfiguration of patient-
provider relations. This is likely to impact on how individuals negotiate their future 
candidacy not only within digital service environments but across the entire sexual health 
delivery system.  
3.5.3 Contextual contingencies  
There are a number of potential contextual factors that may modify the implementation of 
the intervention and the way intervention mechanisms operate.  
1) Given that health seeking preferences are patterned by demographic and psychosocial 
factors (Mackian, Bedri & Lovel 2004), the way in which intervention components 
trigger increased recognition of candidacy is likely to vary across individuals and groups 
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of individuals. Candidacy is also highly contingent on perceived need for care and the 
interpretation of symptoms (Dixon-Woods et al. 2005). Recognition of candidacy for STI 
testing and preferences for health services is likely to be mediated by perception of risk 
and concerns related to recent sexual activity.   
2) The successful navigation of online services, including interactions with health providers, 
will rely on the competencies and resources within the population. As discussed in 
chapter 1, digital services confer new roles and responsibilities onto patients. The theory 
of change suggested the varying competencies in a digital service environment could be 
symbolised by two contrasting user identities (Baraitser et al. 2015).  
First, it envisaged an informed and ‘active’ user, in line with consumer-oriented health 
identities (Lupton 1997; Fox & Ward 2006). This user is characterised by high levels of 
health literacy, confidence and skills to manage their own health needs and to negotiate 
their preferred health care pathways within an online service environment.  
Second, they described a user characterised by potential vulnerabilities on account of 
their (young) age, heightened risk to STIs, social status and lower levels of health literacy. 
It was suggested that these so called ‘vulnerable’ users would be less comfortable with 
this emerging consumer driven construct of patienthood, particularly the potential 
burden implied by the conferral of responsibility from providers to users. Importantly, 
there was concern that existing inequities may become exacerbated, as such users may 
struggle to use an online service independently and may require additional support (and 
potentially vigilance) from health professionals (Baraitser et al. 2015).  
3) SH:24 aimed to provide seamless care pathways that integrate both online and face-to-
face services. The ‘porosity’ of online pathways will depend on the integration of 
clinical and online services. Users with complex needs and symptoms who begin their 
testing journey online will be referred to clinic services, while those diagnosed via 
online pathways will be referred into clinic for treatment. Much will depend on 
whether this integration is deemed acceptable by users and health professionals alike.  
Moreover it is likely that the integration of digital and clinic-based care pathways will 
be influenced by local commissioning policies and procedures.  
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3.6 Chapter summary 
In this chapter, I discussed the merits and challenges of theory-driven approaches to 
evaluation. I posited that a critical realist perspective provides a useful philosophical and 
methodological framing for the evaluation of complex health interventions. I adopted a 
critical realist conceptualisation of causal mechanisms to theorise possible change 
processes triggered by the intervention; and I drew on the ‘candidacy’ lens to conceptualise 
these change processes in relation to access and utilisation of STI testing services. In line 
with realist evaluative approaches, I outlined a number of contextual contingencies that 
may modify the effect of the intervention. The following chapter outlines the study design 
and methods for this evaluation.  
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4.1 Chapter overview  
In this chapter, I outline the rationale and design of the randomised controlled trial that 
was used to evaluate the intervention. I discuss the development of the recruitment 
strategy and how this was employed, in addition to the study follow up procedures.  
4.2 Study design 
The aim of the primary study was to assess the additional benefit of providing e-STI testing 
and treatment service alongside standard care in a pragmatic setting. We implemented a 
parallel group, individual, randomised controlled trial (RCT) in the London boroughs of 
Lambeth and Southwark. Participants were randomly allocated to: 
1) the SH:24 website which offered free self-sampling postal STI kits for chlamydia, 
gonorrhoea, syphilis and HIV, results via SMS text messaging (reactive results for 
HIV delivered by phone), and direct referrals into clinics for treatment;  
2) or to a bespoke sexual health information website with signposting to local clinic-
based sexual health services in Lambeth and Southwark.  
Participants were free to use any other services or interventions during the trial. 
4.2.1 Eligibility 
The trial aimed to evaluate SH:24 among a population with an unmet need for STI testing.  
One way of defining unmet need is on the basis of sexual risk behaviours. For example not 
having tested for STIs in the last 12 months and having at least one episode of condomless 
sex in the same period. However, these criteria might stigmatise potential participants, 
particularly during face-to-face recruitment. The trial was therefore designed to target a 
key population group at risk of STIs, namely young sexually active adults.  
The inclusion criteria were as follows: aged 16-30 years, sexually active (at least one partner 
in the last 12 months), being resident in the London boroughs of Lambeth and Southwark, a 
willingness to take an STI test and access to the internet (owner of a smart phone or able to 
access laptop, tablet, personal computer in their own home).   
Particular efforts were made to ensure the sample population included young MSM and 
black minority ethnic groups, in view of the elevated risk profiles of these socio-
demographic groups. 
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Participants were excluded if they were unable to read in English.  It is possible that this 
criterion excluded vulnerable populations with a need for STI testing. However, at the time, 
the e-STI service under evaluation operated its website in English only. Participants who 
were unable to give informed consent, such as people with severe learning difficulties were 
also excluded on ethical grounds.   
4.2.2 Intervention and control 
Participants in the intervention group were sent a text message with the URL of SH:24 
(www.sh24.org.uk). SH:24 offered free postal self-sampling test kits for chlamydia, 
gonorrhoea, HIV and syphilis.  Participants who ordered a test kit from SH:24, were 
required to complete a short order form, online. Those reporting STI symptoms were 
advised via a pop up message to visit their local clinic for immediate treatment. Those 
reporting complex needs such as depression, drug and alcohol dependency, or exploitative 
sexual partnerships were telephoned by a clinician and referred to relevant clinical services.  
All participants could continue to use the online service if they wished.   
All test kits contained a lancet and collection tube to obtain a blood sample for serological 
testing for syphilis and HIV. For chlamydia and gonorrhoea, women were sent vaginal 
swabs and men were sent a container for first catch urine samples. Test kits for MSM also 
contained swabs to take pharyngeal and rectal samples.  
The tests kits included pictorial leaflets with guidance on how to collect the specimens. A 
video demonstrating blood sample collection was available on YouTube and could be 
accessed via the SH:24 website. Participants were encouraged to text or phone the SH:24 
team with any questions or concerns. Non-returners were sent reminders via text message 
and resent test kits if required, as per SH:24’s protocols.  
Chlamydia, gonorrhoea and syphilis test results were delivered by text message.  
Participants with reactive results for syphilis or positive results for chlamydia and 
gonorrhoea were signposted to local clinics for confirmatory testing and treatment as 
necessary. Reactive results for HIV were communicated by phone by a clinician. The SH:24 
website also provided health education information on sexually transmitted infections and 
safer sex practices.  
Participants in the control arm were sent the uniform resource locator (URL) of a bespoke 
website with the contact details, websites and location (google map image) of sexual health 
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clinics in Lambeth and Southwark. These clinics provided usual care via walk-in services. 
Some clinics also offered an appointment service for those with symptoms or complex 
needs.    All participants were free to use any other sexual health services or interventions 
during the trial period. 
4.2.3 Risk of contamination  
Contamination, whereby some individuals allocated to the control arm receive the 
intervention, and vice versa, can lead to underestimation or overestimation of effect 
estimates. Small levels of contamination are acceptable and can be offset by recruiting 
more participants to the study (Torgerson 2001).  
At the design phase of this study, the possibility of contamination was considered as it was 
plausible that individuals allocated to the intervention could share the SH:24 URL with 
those allocated to the control. It was not a concern if control participants shared the 
control URL, as intervention participants were free to use any other service if they wished. 
To reduce the risk of contamination, an alternative design based on cluster randomisation 
was mooted. For example, randomising entire boroughs might have allowed for greater 
control over the intervention, as access to the website could be restricted to people with 
eligible postcodes, and trial participants from different boroughs might be less likely to 
interact with each other. However SH:24 was funded to deliver e-STI testing in the 
boroughs of Lambeth and Southwark only, and hence a cluster RCT was not feasible. 
Further, a cluster RCT would have required a much larger sample size and budget. Ensuring 
sufficient comparability between boroughs with respect to the underlying STI epidemiology 
of the population, and the characteristics of ‘usual’ face-to-face care might also have 
proved challenging.  
To minimise the risk of contamination between groups the following sentence was included 
in the intervention text message, ‘Please do not share this link with anyone’. During 
recruitment, SH:24 monitored the proportion of the control arm who accessed the SH:24 
website, by cross checking control participants’ mobile phone numbers with the SH:24 
database.  
4.2.4 Changes to the control conditions 
Recruitment began in November 2014. Initially the SH:24 website and service was available 
only to trial participants. However, in order to comply with their funding agreement, SH:24 
launched the service to the general public in Lambeth and Southwark in March 2015. They 
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opted for a soft launch, without the use of large scale advertising. Nevertheless the launch 
of the service changed the composition of usual care, as the SH:24 website was promoted 
in face-to-face clinical settings. This was considered in the analyses by assessing if the effect 
of the intervention on our co-primary outcomes was modified by the launch of SH:24 (see 
section 5.3.3).     
4.2.5 Laboratory processing and diagnostic testing platforms  
The intervention provided postal self-sampling test kits for gonorrhoea, HIV, syphilis and 
chlamydia which were processed by The Doctors Laboratory (TDL). Chlamydia and 
gonorrhoea are detected by BD Viper Platform/ BD Assay. Positive Gonorrhoea results were 
confirmed using Cepheid GeneXpert (Dual Target). 
HIV I and II/p24Ag were detected by Roche Platform/ Roche Assay and Syphilis IgG/IgM by 
Abbott Architect/Abbott Assay.  
Reactive results for HIV and syphilis required a confirmatory assay performed in clinic 
settings.  Any unconfirmed reactive results in the intervention were counted as negative 
test results.  
4.2.6 Primary outcomes 
The co-primary outcomes were self-reported diagnosis of an STI at 6 weeks, confirmed by 
patient health records, and self-reported completion of an STI test at 6 weeks, confirmed by 
patient health records. Completion of an STI test was defined as samples processed by the 
laboratory and results delivered to SH:24 or to clinic. 
4.2.7 Secondary outcomes 
Secondary outcomes were the proportion of participants prescribed treatment for an STI, 
time from randomisation to completion of an STI test, and time from randomisation to 
treatment of an STI. 
4.2.8 Process outcomes 
Process outcomes were the proportion of STI tests that were positive in each group, 
median time from diagnosis to treatment in each group, the proportion of participants who 
completed an STI test in each group by service type, the proportion of participants 
diagnosed in each group by service type, and, in the intervention group only, the 
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proportion who agreed that the intervention was acceptable and the proportion who 
adhered to an appropriate e-STI testing pathway.  
All pathways were considered appropriate unless participants completed a test via SH:24, 
received a negative result, and then retested for the same STI in a face-to-face setting 
within 6 weeks.  
In addition to the pre-specified process outcomes, the proportion of participants who 
tested positive for an STI among those who completed a test at 6 weeks, with 95% 
confidence intervals are reported. 
4.2.9 Sample size 
The study was powered for the first co-primary outcome measure which is the proportion 
of participants diagnosed with at least one STI in each arm. Two factors determined the 
number of participants needed for this trial: the estimated proportion of participants with 
an STI and the size of the treatment effect.  
These estimates were based on the following data: 
In 2014, the Greenwich sexual health service demonstrated a 50% return rate among users 
who order test kits online (personal communication Dr David Pinson, Health Improvement 
Principal, Royal Borough of Greenwich). Eligibility for this study was restricted to people 
who were willing to take an STI test. However, not all of those allocated to the intervention 
group were likely to order a test kit. It was estimated that 30% would not complete this first 
step. Among the 70% who ordered a kit, it was assumed that 50% would return the kit for 
analysis, based on the Greenwich data. Following these assumptions, 35% of the 
intervention group were likely to complete an STI test. 
There were no available data which would give us an estimate of the likely numbers that 
will get tested in the control group. However, it was assumed that far fewer people (10%) 
were likely to seek a test in clinic-based settings.  
Chlamydia is the most commonly diagnosed STI of the four STIs of interest in this study 
both at the national level (England) and at the local authority level (Lambeth and 
Southwark) (Public Health England 2017d; Public Health England). The prevalence estimates 
are based on the proportion of positive chlamydia tests among 15-24 year olds in general 
practice settings in Lambeth and Southwark, which was 6% in 2012 (Public Health England).  
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The estimated losses to follow up on were based on previous eHealth studies in the United 
Kingdom which have achieved 90% follow up (Free et al. 2011). 
A sample size of 3000 would lead to 90% power (two-sided alpha=5%) to detect a relative 
risk of 3.5, (2.1% risk of diagnosis in the intervention group vs 0.6% risk of diagnosis in the 
control group), allowing for 10% losses to follow up. This equates to 10% of the control 
group being tested, with a 6% probability of infection as in general practice settings and 
35% of the intervention tested with a 6% probability of infection as in general practice 
settings.  
With regard to the co-primary outcome measure, a trial with 3000 participants we would 
have 99% power (two-sided alpha=5%) to detect an absolute difference of 25% between 
the proportion of participants who complete a test in the intervention group versus the 
proportion who complete a test in the control group (35% versus 10%). 
4.2.10 Ethical approval  
Ethics approval was granted by the National Research Ethics Service Committee London-
Camberwell St Giles (ref 14/LO/1477). The trial is registered with Current Controlled Trials, 
number ISRCTN13354298. 
4.3 Statistical analyses  
Randomisation was based on a minimisation algorithm to balance key prognostic 
covariates. Minimisation introduces correlation between treatment groups and this 
requires an adjusted analysis (Kahan & Morris 2012). Ignoring minimisation factors leads to 
the incorrect estimation of the standard error for the treatment effect, which is biased 
upwards in an unadjusted analysis (Kahan & Morris 2012) . Accounting for correlation 
between groups therefore ensures no loss of power, confidence intervals of the correct 
width and correct type 1 error rates (Kahan et al. 2014).  
The adjusted analyses were based on a propensity score approach. Propensity score 
methods are commonly used to adjust for confounding in the estimation of causal effects 
using observational data (Austin 2011). In individually randomised controlled trials, where 
confounding is not an issue, propensity score methods, and specifically inverse probability 
treatment weighting (IPTW), can be used to adjust for chance imbalances of prognostic co-
variates between treatment arms (Williamson, Forbes & White 2014). In the case of 
balanced randomisation such as minimisation, IPTW can adjust for the balancing variables, 
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thus breaking the dependency in the data between treatment groups.  In both cases, 
adjustment of baseline prognostic factors using IPTW increases the precision of effect 
estimates (ibid.).   
The outcome models used an inverse probability of treatment estimator, to estimate the 
average treatment effects (ATE) on the co-primary outcomes. In these models the ATE is 
expressed as the weighted risk difference between the intervention group and the control 
group. Weighted risk ratio estimates and their confidence intervals were obtained via the 
delta method of transformation. I report the p-values from the treatment effects model, 
which correspond to the null hypothesis of the risk difference parameter.  
The propensity score for treatment allocation was estimated from all minimisation factors 
(gender, age, sexual orientation and number of sexual partners in the last 12 months) in 
addition to ethnicity, as this is also a predictor of the co-primary outcomes (Fenton et al.).  
4.3.1 Handling of missing data  
Differential losses to follow up were anticipated, as outcome data at the SH:24 service were 
captured on a single database, whereas in the clinic arm, participants had the choice of a 
number of clinics, which required searches of patient records at multiple sites (see section 
5.7). It was hypothesised that participants in the clinic arm might choose to use clinics 
outside of the study area (Lambeth and Southwark), which would prove more challenging 
for data collection.  
Losses to follow up, irrespective of whether they are differential or not, can lead to biased 
estimates if appropriate methods are not used to handle missing data (Bell et al. 2013). 
Missing data also reduces power and efficiency. We accounted for missing data using 
multiple imputation techniques assuming data were Missing at Random (MAR). Under this 
assumption, the distribution of the outcome for both missing and non-missing groups is 
conditional on observed data, and independent of the unobserved data (Carpenter & 
Kenward 2008, p.12).  
Imputation was based on Multivariate Imputation by Chained Equations (MICE). The two 
co-primary outcomes (testing and diagnoses) and the secondary outcome (treatment) were 
imputed using three conditional models. Self-reported outcomes were included as these 
are auxiliary variables that provide partial information for missing groups.  
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Each model included randomised group as a covariate and was weighted by the inverse of 
the estimated propensity score (for compatibility with the model for analysis). In addition, 
the two models to impute STI testing and STI diagnosis conditioned on self-reported 
testing, self-reported diagnoses and self-reported treatment, which were also incomplete.  
The model to impute treatment conditioned on self-reported testing and self-reported 
treatment only, due to collinearity with other variables, which led to non-convergence. 
Each incomplete variable conditioned on other incomplete variables. Each imputed dataset 
was produced with 10 cycles.  One hundred imputed datasets were generated for each 
missing outcome. Multiple imputation inference proceeded via Rubin’s rules (Rubin 1987). 
For the publication of the RCT results, Dr. Tim Morris (TM) performed a sensitivity analysis 
to explore departures from MAR.  Under this assumption, the distribution of outcome is 
assumed to be different between those with missing data and those with the outcome 
observed, after adjusting for observed covariates.   
TM multiply imputed missing outcome data, using inverse probability weighting on the 
estimated propensity score and with allocated group and self-reported testing, diagnoses 
and treatment as covariates. The odds of STI diagnosis and the odds of a completed STI test 
for missing participants were varied to be ¼, ½, 1, 2 and then 4 times larger than the MAR 
analyses. This was done factorially for the two randomised arms, giving a total of 25 
analyses (including the principal analysis assuming MAR).  
4.3.2 Missing covariates  
All baseline characteristics were fully observed, except for sexual orientation as participants 
could opt out of this question. A missing category was therefore used (coded 99 in Stata).  
4.3.3 Subgroup analyses 
To explore heterogeneity of the intervention effect on the co-primary outcomes, 
interaction tests at a 5% level of significance were carried out to assess whether 
effectiveness varied by the following baseline characteristics: gender (male, female); 
ethnicity (White, Black/ African/ Caribbean/ Black British, Asian/Asian British/ All other 
groups); sexual orientation (msm, all other groups); age group (16-19 years, 20-24 years, 
25-30 years); number of sexual partners (1, 2+); and index of multiple deprivation (IMD) 
rank (linear). We also tested possible heterogeneity of effect that may have resulted as a 
result of SH:24’s launch to the general public (see section 4.2.4.). Effectiveness was 
compared prior to SH:24’s launch and post launch.  
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These analyses were conducted in the complete cases under a MAR assumption using a log 
binomial model.  They were not weighted by the inverse of the estimated propensity score, 
as specified in the analysis plan, due to non-convergence of the models. Given that the 
study was not powered to test for interactions, these analyses were designed to be 
exploratory and the statistical significance of the interaction tests have been interpreted 
with caution. 
4.3.4 Time to event analyses 
Survival analysis was used to estimate the restricted mean survival time (RMST) from 
randomisation to completion of an STI test and prescription of treatment for each group. 
The Royston Palmar semi-parametric method was used to estimate the restricted mean 
survival time. The RMST is an appropriate measure even when the proportional hazard 
assumption is in doubt (Royston & Parmar 2011).  As with other analyses, the RMST 
accounted for covariates by weighting on the inverse of the estimated propensity score.  
The mean survival time was set to t* = 6 weeks (42 days) for time-to-test and t* = 3 months 
(84 days) for time-to-treatment.  
4.4 Recruitment  
4.4.1 Overview  
I led the design and implementation of the recruitment strategy for the trial. Assisted by 
colleagues from Kings College London, and a small team of research assistants, I 
approached community networks, organizations, and institutions such as further education 
colleges, universities, patient groups, sexual health advocacy groups, sports centres, 
entertainment and leisure venues and major employers to recruit participants. We also 
utilized social media sites popular among our study population. These included Facebook, 
Twitter, and dating applications for gay and bisexual men such as Scruff and Grindr.  
4.4.2 Informed consent 
After potential participants were assessed for their eligibility, they were provided with 
detailed verbal and written information about the study, and given the opportunity to ask 
any questions. If the participant agreed to participate, we asked them to provide consent 
via the trial website (e.g. using a mobile phone or tablet) or via paper-based forms. If 
potential participants wanted more time to consider their involvement, we gave them the 
contact details of the study coordinator so that they could talk through any queries or 
doubts.  
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Potential participants were also able to access the study website independently, for 
example via social media sites.  
4.4.3 Developing the ‘offer’ of the RCT 
Prior to recruitment, I conducted informal focus group discussions with local residents of 
Lambeth and Southwark and the Sex Positive group at Brook Young People. The aim of this 
formative research was twofold:  1) to understand what might motivate young people to 
enrol in the study; and 2) to determine how to communicate the objectives of the trial in a 
non-technical way.   
 The main learning from this research was as follows: 
- The enrolment process should be quick and straightforward. Ideally, participants 
should be able to enrol on their smart phones and the baseline questionnaire 
should be short; 
- Participants should be offered a financial incentive for taking part and young 
peoples’ time should be respected;  
- The potential benefits of the study for young people should be emphasised. These 
include opportunities to shape local sexual health service provision and to screen 
for STIs thereby taking care of one’s health. 
Based on this feedback, I developed some simple messages to facilitate the promotion of 
the trial in community settings. These are as follows: 
 “Help us improve sexual health services, get tested, get £10 for your time” 
“Thinking about a sexual health check? Get tested, get £10” 
These messages were then included in the promotional materials (Figure 7) 
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Figure 7. Promotional leaflet and web banner 
 
In order to avoid performance bias, we did not advertise that we were evaluating an e-STI 
testing service. Instead we informed potential participants that the purpose of the study 
was to evaluate sexual health services in Lambeth and Southwark more broadly. We 
explained that there are many types of sexual health services available in the boroughs, and 
if they chose to take part, they would be invited to use one type of service. This approach 
was approved by our ethics committee.  
4.4.4 Face-to-face recruitment  
RCTs of sexual health interventions have successfully recruited students in universities in 
the UK (Ivaz et al. 2006). Initially I contacted four universities in South London (Goldsmiths, 
Kings College London, Southbank University and London College of Arts), where I proposed 
entering lecture halls at the beginning or end of lectures to give a brief 5 minute overview 
of the study and give students the opportunity to enrol. I also approached two further 
education colleges – Lewisham Southwark College (LeSoCo) and Lambeth College – with a 
view to giving more in-depth educational talks on sexual health to sensitise students on the 
benefits of STI testing.   
I felt that these strategies would give the study team exposure to high volumes of young 
people, who may reside in South London. In principal, these institutions were highly 
supportive of the study and granted approval for the team to be on campuses. However, 
access to classrooms and lecture halls had to be negotiated with individual teachers and 
lecturers, which was extremely time-consuming.  
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I therefore revised our approach. Rather than targeting students in classrooms and lecture 
halls, we held regular stalls in student unions, halls of residences, major thoroughfares (e.g. 
outside large lecture halls), bars and eating venues. I also worked closely with student 
societies (such as KCL Sexpression society) during events such as HIV testing week. This 
proved highly effective and we succeeded in recruiting 269 participants during this first 
week of recruitment (Figure 8).    
4.4.5 Online recruitment 
Social media platforms offer an alternative avenue to promote sexual health studies. The 
Sexunzipped trial recruited primarily via Facebook advertising in the UK (Bailey et al. 2013), 
while 44% of participants in the 2014 English Gay Men’s sex survey (2014) were recruited 
via dating apps, such as Grindr (Hickson et al. 2016).  
Together with a systems developer, I designed an enrolment system that allowed 
participants to self-enrol remotely via the trial website. Initially there was a concern that 
advertising the trial on social media might result in high levels of contamination (for 
example if intervention participants chose to share the intervention URL via twitter or 
0
500
1000
1500
2000
2500
C
u
m
u
la
ti
ve
 n
u
m
b
e
r 
o
f 
p
ar
ti
ci
p
an
ts
 r
e
cr
u
it
e
d
   
Recruitment timeline
All recruitment
Social media and
dating apps
Face-to-face
Friend
recommended
Figure 8. Recruitment timeline by main method of recruitment 
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Facebook).  However, it proved difficult to sustain the intensity of face-to-face recruitment 
and as figure 8 demonstrates, face-to-face recruitment began to taper off in February 2015.  
We therefore took the decision to try online recruitment in February 2015. Jonathan Syred 
from KCL ran a series of successful campaigns via Facebook, twitter and the MSM dating 
app, Grindr, recruiting a total of 1,079 participants. 
4.4.6 Other forms of recruitment  
I contacted key organisations working on sexual health in Lambeth and Southwark to 
promote the trial via their youth engagement work. These included Brook Young People, 
Southwark Council and Healthwatch. Together with a research assistant, I attended 
relevant events (such as health fayres or discussion groups) and accompanied health 
promoters during their visits to colleges and housing estates.  
A key concern during recruitment was the low numbers of participants from BME groups. In 
July 2015 I contacted two health promoters from SHAKA services - a sexual health 
organisation working with BME communities in South London. They promoted the study, 
together with the study coordinator, as part of their outreach activities in barber shops, 
hairdressers and community markets.  
Forging relationships with these organisations was time-intensive and did not yield high 
numbers of participants. Much of the outreach work conducted by these groups was not 
well coordinated and did not engage significant numbers of young people. Nevertheless, 
these partnerships enabled participation (albeit in very low numbers) by individuals from 
more marginalised communities, who were not reached by face-to-face and online 
strategies.        
Figure 9. Example of Twitter advertisement 
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Other methods used to promote the trial included leafleting large housing estates, 
advertising via online media targeting MSM such as QX and Boys. However, while increasing 
the visibility of the trial, these methods did not yield many enrolments. 
4.4.7 Recruitment of key population groups 
The proportion of participants from non-white ethnic backgrounds was highest among 
those recruited in university or further education colleges (Figure 11). The proportion of 
black or black British groups was lowest among those recruited via MSM dating apps.   
 
Those recruited in face-to-face settings (university or college) had a lower sexual risk profile 
with respect to the number of sexual partners in the last 12 months, compared to those 
who were recruited remotely (via social media or dating apps). It is plausible that those 
with a higher number of sexual partners may have felt less comfortable engaging with the 
study team in public spaces, for fear of being judged. As expected, those recruited via MSM 
dating apps had more frequent partner change in the previous 12 months compared to 
those recruited by other methods.  
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4.4.8 Lessons learned  
o Reaching black and minority ethnic groups proved challenging. A high proportion of 
students at further education colleges are from BME backgrounds. For example 
approximately 60% of LeSoCo students identify as BME (Lewisham Southwark 
College no date).   However, we were unable to gain access to the classrooms in 
these colleges, and unlike the universities, there was limited social infrastructure 
(such as student societies), which could facilitate engagement outside of the 
classroom. On reflection, we required greater buy-in from senior management at 
these colleges. With more time and resources, it also might have been feasible to 
develop an effective outreach strategy to reach BME communities in the boroughs.   
o Advertising via social media platforms is efficient as advertisements can target 
populations with specific socio-demographic characteristics and by geographical 
location (determined by users IP addresses).  In face-to-face settings, particularly in 
universities, we encountered large numbers of young adults who were not eligible 
as they did not reside in Lambeth and Southwark.   
Nevertheless there were inefficiencies later in the online enrolment pathway. There 
was a very high drop off rate after participants ‘clicked through’ to the study 
welcome page. During the 9 months of recruitment (24/11/2014 – 31/08/2015) 
34,124 new users1 landed on the study welcome page, but only 8,330 (24.4%) 
clicked through to the study information sheet. The transition from highly optimised 
platforms such as Facebook to the study website, which was far less user friendly 
(particularly on a mobile phone), may have acted as a strong deterrent. Although it 
is also plausible that potential participants may have been deterred by the 
requirements of the study.  
o Engagement with non-governmental organisations and other community groups in 
Lambeth and Southwark did not yield many enrolments. We found it difficult to 
explain the study objectives, and there was some confusion as to why we could not 
reveal that we were evaluating an online service (see section 4.5.3). We found that 
outreach activities and sexual health promotion were not well-coordinated in the 
boroughs, which is of concern considering the high rates of infection.  
                                                          
1 Data include participants recruited in face-to-face settings who enrolled via tablets or mobile phones  
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4.5 Data collection - self reported 
4.5.1 Baseline data  
At enrolment, participants were asked to enter their baseline data directly onto the trial 
website or to complete a paper-based form (Appendix 4). We collected the following 
information: 
• Contact details: first name, surname, main mobile number, email address, primary 
postal address.  
• Demographic data: date of birth, gender, ethnicity, sexual orientation.  
• Sexual health behaviours: last STI test, service used at last STI test, number of 
sexual partners in the last 12 months  
Other markers of sexual risk were considered, such as condomless sex in the last 12 
months, as well as additional socio-demographic data, such as participants’ education level.  
However we decided against a lengthy baseline questionnaire in order to keep the 
enrolment procedures to a minimum.  
I matched participants’ postcodes to the national index of multiple deprivation (IMD). IMD 
is a relative measure deprivation that ranks every small area in England from 1 (most 
deprived area) to 32,844 (least deprived area)(Department for Communities and Local 
Government). As an area level measure of deprivation, IMD can not be used to draw 
conclusions about deprivation at the individual level. Nevertheless, studies have found IMD 
to be useful marker of inequity with respect to the availability of services, given that 
services are often commissioned on an area level basis (Sonnenberg et al. 2013).  
4.5.2 Follow up instrument 
The follow up instruments (Appendix 5) asked participants if they used a service to test for 
STIs, which type of service they used and to state their results and any treatment 
prescribed. If they used a service, they were asked to assess the acceptability of the service. 
If they stated that they did not use a service, they were asked the reasons for declining the 
invitation to test.  
It was beyond the scope of this project to develop a validated scale to assess service 
acceptability in the context of e-STI testing. We therefore selected four individual questions 
from a patient satisfaction questionnaire validated for use in GUM clinics (Weston et al. 
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2010). We modified the questions to ensure they were relevant to an online service. These 
questions do not have any psychometric properties. 
Did you feel that your personal information was kept confidential by this service? 
A. Yes (2), B. Yes to some extent (1) C. No (0) 
 
Did you have trust in the clinical expertise of this service? 
A. Yes (2), B. Yes to some extent (1) C.  No (0) 
 
Would you use this service again if you needed to? 
A. Yes definitely (2) B. Yes, probably (1) C. No (0) 
 
Would you recommend this service to a friend? 
Yes definitely (2) B. Yes, probably (1) C. No (0) 
Acceptability was constructed as a binary variable. A score of 8 was coded as 1 (acceptable); 
a score <8 was coded as 0 (not acceptable).  
The follow up forms were piloted among clinic users to gauge their understanding of the 
questions and their acceptability of the questionnaire, prior to commencing follow up.   
4.5.3 Follow up procedures 
I used evidence based methods to ensure high response rates (Edwards et al. 2002). These 
include providing incentives to all participants, contacting respondents prior to sending 
questionnaires and contacting non-responders using phone call, texting, email. 
At 6 weeks from randomisation all participants were sent a hard copy of the follow up form 
together with a £5 cash incentive. Within 5 days of posting the form, I sent a text message 
to remind participants that on receipt of the completed questionnaire they would receive a 
further £5.  
The text message also included a link to a web -based version of the follow up form. 
Participants were sent a further two text message reminders.  
4.5.4 Discrepant and incomplete data 
EW, together with two research assistants, telephoned participants who returned 
discrepant data. For example, a number of participants stated that they did not get an STI 
test but completed the section on acceptability, suggesting that they did in fact get a test.  
In addition, if participants stated that they tested, but there was no record found in any of 
the services in Lambeth and Southwark, we called them to ask if they had used a different 
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type of sexual health service (for example a GP service or GUM clinic outside of Lambeth 
and Southwark).  
4.5.5 Non responders 
Between November 2015 and January 2016, we contacted all non-responders via text 
message, email and phone.  
4.5.6 Data collection - objective  
I collected objective outcome data between October 2015 and June 2016. Data managers 
at Kings College Hospital NHS Foundation Trust and Guy’s and St. Thomas’ NHS Foundation 
Trust searched the patient record databases for all randomised participants.  I also 
searched the SH:24 orders database for all randomised participants.  
If a participant reported using a different service (e.g. a GP surgery or other sexual health 
service in London or the UK), I contacted the service to verify if the participant attended the 
service between the date of randomisation and the date when follow up was collected (as 
per the date logged in the follow up database). If the participant attended the service 
within this time period, we requested data on STI tests completed, STI test results and 
treatment prescribed. 
Given that GUM and secondary sexual health services in the UK are anonymous and not 
linked to patients’ NHS numbers, I used the following identifiers to locate participants’ 
health records: 
Table 3. Identifiers used in patient record checks 
Service Identifier 
Walk-in GUM clinics & 
SH:24 
− Mobile phone number AND Gender (and/or) 
− Name AND Date of birth 
GP surgeries  − Name AND Date of birth 
4.6  Assessment of primary endpoints  
The co-primary outcome measures are:  
• Self-reported diagnosis of at least one STI at 6 weeks (42 days), confirmed by 
patient health records.   
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• Self-reported completion of at least one STI at 6 weeks (42 days), confirmed by 
patient health records.  
I defined ‘Completion’ of an STI test as samples returned, processed by the laboratory, and 
results uploaded onto the information management systems of the clinic or intervention.   
Most participants tested for more than one infection. If one test result was received within 
42 days of randomisation, I counted all tests and diagnoses linked to that index clinical 
attendance or index internet test order.  If a participant used a service on the same day as 
randomisation, I assumed they were randomised first.  
The data received from GUM settings were coded according to the coding framework for 
Sexual Health and HIV Activity Property Types. These are as follows: 
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Table 4. Public Health England SHHAPT codes for testing services – summary of definitions (Public 
Health England)   
HIV only  
HIV antibody test P1A 
HIV test offered & refused P1B 
HIV test not appropriate P1C 
STI  
Chlamydia only T1 
Chlamydia & gonorrhoea  T2 
Chlamydia, gonorrhoea & syphilis T3 
Chlamydia, gonorrhoea, syphilis & HIV T4 
HSV (herpes simplex virus) T5 
Hepatitis A / B / C T6 
Syphilis & HIV T7 
Self-sampling (no HCW consultation) T8 
STI tests not required T9 
Rapid testing (same day results) T10 
Microscopy  TS 
3 site testing TT 
 
I counted all codes related to laboratory based STI testing. These included P1A, T1, T2, T3, 
T4, T5, T6, T7. Other activity, such as clinical examination for the presence of STIs (e.g. 
genital warts) were not counted.  
I counted all new diagnoses arising from laboratory testing for STIs and not those arising 
from clinical examination or microscopy.  I discounted existing diagnoses for STIs (e.g. 
previously diagnosed HIV infection).  
I counted STI treatment where a person was treated and received a positive laboratory test 
for STI. Treatment could be provided presumptively as long as it was accompanied by 
positive laboratory test result.     
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4.6.1 Verification of self-reported data  
If a participant reported completing an STI test in any named service between the date of 
randomisation and the date of follow up, a data search was subsequently conducted in the 
named service for that corresponding time period.  
Some participants in the control arm reported completing an STI test in a sexual health 
clinic but did not provide the name of the clinic. Their data were considered to be 
objectively verified if an attendance record for STI testing or clinical examination for STI was 
retrieved from the services in Lambeth and Southwark, between the date of randomisation 
and the date of follow up. Given that the clinic arm was invited to test in the sexual health 
clinics in Lambeth and Southwark, it is reasonable to assume that this is the clinical 
experience that they were referring to. Attendances for STI testing and clinical 
examinations for STI were counted, but not other non-STI services such as contraception, 
vaccinations, and cervical cytology.  
If a participant did not submit a 6 week outcome questionnaire but they completed an STI 
test via SH:24 or one of the sexual health clinics in Lambeth and Southwark within 42 days 
of randomisation, they were counted as having tested.  
If a participant reported that they were prescribed treatment for a sexually transmitted 
infection in a named service, but a record could not be found in that service, then they 
were counted as not prescribed treatment.  
If a participant reported data by more than one mode (e.g. via the web-based form and via 
hard copy questionnaire) the first data received were the data used for analysis. The only 
exceptions to this rule were:  
• If a participant submitted incomplete data via the web-based data collection portal 
and subsequently submitted complete data on the same day, the latest data 
collected will be the data used for analysis. 
• If a participant has been contacted to verify their answers (e.g. to ask for the name 
of the service used or to clarify discrepant data), the latest data collected were 
used for analysis.  This included participants who originally indicated that they 
tested but subsequently changed their answer.  
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4.7 Chapter summary  
In this chapter, I discussed the study methods and procedures for the RCT. In addition, I 
outlined the recruitment strategy, and lessons learned from the employment of this 
strategy. In the following chapter, I present the main results from the RCT.   
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5.1 Chapter overview 
This chapter is an extended version of the published trial report (Wilson et al. 2017). I 
replicated the original analyses that were conducted by the trial statistician and therefore 
some results may differ slightly from the main publication.  
5.2 Baseline characteristics  
2,072 participants were randomly assigned to the SH:24 online testing and results service or 
to the control group (Figure 13). We excluded 8 participants who were randomised twice 
and 1 participant who was randomised and did not meet the age criterion (Figure 13). We 
were unable recruit to target and therefore we lacked power for the co-primary outcome of 
STI diagnoses.  
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Figure 13. CONSORT flow diagram 
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Baseline characteristics are presented in Table 5.  
Table 5. Baseline characteristics of participants 
 Intervention group Control group 
 (n=1031) (n=1032) 
Sex    
Female 604 (58.6) 609 (59.0) 
Male 424 (41.1) 422 (40.9) 
Transgender 3 (<1) 1 (<1) 
Mean age (years) 23 (3.5) 23 (3.6) 
Age group (years)   
16-19  206 (20.0) 220 (21.3) 
20-24  440 (42.7) 432 (41.9) 
25-30  385 (37.3) 380 (36.8) 
Sexual Orientation    
Men who have sex with men  129 (12.5) 133 (12.9) 
Other 890 (86.3) 888 (86.0) 
Refused  12 (1.2) 11 (1.1) 
Partners    
1 302 (29.3) 304 (29.5) 
2+ 729 (70.7) 728 (70.5) 
Ethnic Group   
White/ White British 779 (75.6) 749 (72.6) 
Black/ Black British 81 (7.9) 110 (10.7) 
Asian/ Asian British 70 (6.8) 57 (5.5) 
Mixed/ Multiple ethnicity 89 (8.6) 99 (9.6) 
Other 12 (1.2) 17 (1.6) 
Last STI test (months)   
0-3 144 (14.0) 155 (15.0) 
3-6 161 (15.6) 140 (13.6) 
6-12 181 (17.6) 165 (16.0) 
12+ 301 (29.2) 288 (27.9) 
Never 244 (23.7) 284 (27.5) 
Place of last STI test   
Sexual health clinic 521 (50.5) 494 (47.9) 
GP 121 (11.7) 115 (11.1) 
Hospital 51 (4.9) 43 (4.2) 
Pharmacy 7 (0.7) 11 (1.1) 
Internet STI test 32 (3.1) 28 (2.7) 
Other 55 (5.3) 55 (5.3) 
N/A 244 (23.7) 286 (27.7) 
Data are n (%) or mean (SD) 
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Primary outcome data, prior to multiple imputation, were available for 921 (89%) 
participants in the intervention group and 818 (79%) in the control group (Figure 13).  
The proportions of participants in each arm who reported completing a test at 6 weeks, and 
who were confirmed to have tested via patient record checks, are provided in figure 14 and 
figure 15. Record checks in clinics, SH:24 and GP surgeries were completed by 17 June 2016. 
5.3 Primary analyses  
The primary analyses were based on multiply imputed datasets.  1,031 in the intervention 
arm and 1,032 in the control arm were included in the analyses. At 6 weeks, 48.4% of the 
intervention group had completed an STI test compared to 24.6% in the control group (RR 
1.97, 95% confidence interval 1.74 to 2.22, P<0.0001; Table 6). 2.3% of the intervention v 
1.2% in the control had been diagnosed with an STI (RR 2.14, 95% confidence interval 1.08 
to 4.25, P=0.0522; Table 6).  
There were similar results for the complete case analysis. In the main trial analyses, the 
results were similar to all the scenarios that we investigated under the assumption that our 
missing outcome data are Missing Not at Random (MNAR). These are reported in the 
published trial report (Wilson et al. 2017) and in the appendices (Appendix 6).  
The effect on the proportion of participants treated was 1.7% in the intervention v 1.0% in 
the control (RR 1.85, 95% confidence interval 0.85 to 4.01, P=0.18; Table 6). 
In the complete cases, time-to-test, estimated by the restricted mean survival time, was 
shorter in the intervention arm compared to the control arm (28.8 days vs 36.5 days; 
P<0.0001, Table 7); no differences were observed for time-to- treatment (83.2 days vs 83.5 
days; P=0.51, Table 7). 
                                                          
2 The p-value relates to the risk difference and these are coherent. The risk ratio is estimated from 
parameters of the same model but its confidence intervals are computed using a delta method 
transformation of the standard errors. As the proportions are close to zero, the transformation is highly 
nonlinear which gives confidence intervals for the risk ratio that are inconsistent with the p-value for the 
risk difference. 
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Table 6. Primary and secondary outcomes 
  Intervention Control Risk difference Relative risk P value 
  n=1,031 n=1,032 (95% CI) (95% CI)  
Primary outcomes        
Diagnosis of STI at 6 
weeks 
Weighted MICE 2.3% 1.2% 1.3% (0.0, 2.6) 2.14 (1.08, 4.25) 0.052* 
 
Weighted 
Complete cases 
2.1% 
(19/921) 
1.0% 
(8/818) 
1.3% (0.1,2.4) 2.35 (0.45, 4.24) 0.031* 
Completion of STI test 
at 6 weeks 
Weighted MICE 48.4% 24.6% 23.7% (19.4, 28.1) 1.97 (1.74, 2.22) <0.0001 
 
Weighted 
Complete cases 
47.7% 
(439/921) 
21.1% 
(173/818) 
26.2% (22.0-30.4) 2.24 (1.91-2.57) <0.0001 
Secondary outcomes  
 
     
STI cases treated  Weighted MICE 1.7% 1.0% 0.8% (–0.4, 2.0) 1.85 (0.85, 4.01) 0.18 
 
Weighted 
Complete cases 
1.2%  
(11/913) 
0.9% 
(7/817) 
0.5% (-0.5,1.4) 1.59 (0.11,3.07) 0.322 
MICE: Multiple Imputation by Chained Equations (number of imputations =100). All estimates (including proportions) are derived from multiply imputed 
data sets.  
*The p-value relates to the risk difference and these are coherent. The risk ratio is estimated from parameters of the same model but its confidence 
intervals are computed using a delta method transformation of the standard errors. As the proportions are close to zero, the transformation is highly 
nonlinear which gives confidence intervals for the risk ratios that are inconsistent with the p-values for the risk difference.
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Figure 14. Self-reported data verified via patient record checks (intervention group).  
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Figure 15. Self-reported data verified via patient record checks (control group).  
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Table 7. Secondary outcomes (time to event) 
 Intervention Control RMST difference P value 
 
RMST (SE) RMST (SE) (95% CI)  
Secondary Outcomes 
   
 
Time to test (t*= 42 days) 28.8 (0.5) 36.5 (0.4) 7.7 days (6.4, 8.9) <0.0001 
Time to treatment (t*= 84 days) 83.2 (0.3) 83.5 (0.2) 0.3 days (–0.6, 1.2) 0.51 
RMST: Restricted Mean Survival Time. Estimates derived from complete cases. 
Kaplan Meier plots for time-to-test and time-to-treatment are presented below (Figure 16, 
Figure 17). The survival curves for time-to-test indicate that the effect of the intervention 
on STI testing is time dependent.  
 
 
Figure 16. Kaplan Meier Plot. Time-to-test.  
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There is evidence that the effect of intervention on STI testing may be modified by gender.   
There is no evidence of heterogeneity for any of the other pre-specified subgroup analyses, 
conducted in the complete cases (Figure 18, Figure 19). Given that there was a lack of 
power for the analyses of STI diagnoses, the subgroup analyses for this outcome are even 
more underpowered. 
Figure 17. Kaplan-Meier Plot. Time-to-treatment 
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Figure 18. Effect of the intervention on STI testing, by subgroup 
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Figure 19. Effect of the intervention on STI diagnoses, by subgroup  
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5.3.1 Process outcomes  
Among participants who completed an STI test at 6 weeks, 4.3% (19/439; 95% CI 2.8-6.7) 
tested positive for an STI in the intervention group and 4.6% (8/173; 95% CI 2.3-9.0) of 
participants tested positive for an STI in the control group. The median time from diagnosis 
to treatment among those with complete treatment data was 2 days in the intervention 
group and 4 days in the control group (Table 8).  Four of the 18 cases treated received 
treatment prior to a laboratory confirmed diagnosis, and are not included in these summary 
statistics.  The excluded cases were evenly distributed between groups.  
Table 8. Process outcomes 
  Intervention Control 
Adherence to appropriate testing pathways at 6 weeks 99.2% (0.4) - 
Self - reported acceptability of intervention at 6 weeks 71.1% (2.6) - 
Median time from diagnosis to subsequent treatment 
(days) among those with complete treatment data (n=9 
in the intervention; n=5 in the control) 
2 days (1 - 5) 4 days (1-7) 
Data are % (SE) and median (IQR) 
76% (294/ 388) of the intervention group who tested via SH:24, provided acceptability data. 
Of these, 71% (209/294) found the intervention to be acceptable (Table 8). 
88% (388/439) of participants in the intervention group who completed an STI test at 6 
weeks, tested via SH:24 (Table 9). 19 participants in the intervention arm were diagnosed 
with an STI. Of these, 12 were diagnosed via SH:24 and 7 were diagnosed in a sexual health 
clinic (Table 9).  
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Table 9. Proportion of participants who completed an STI test and proportion of participants 
diagnosed with an STI, by service type 
  STI test completion STI diagnoses 
  Intervention Control Intervention Control 
Sexual health clinic in Lambeth and 
Southwark  
41 (9%) 145 (84%) 3 (16%) 4 (50%) 
Other sexual health clinic  9 (2%) 15 (9%) 4 (21%) 3 (38%) 
GP 1 (<1%) 2 (1%) 0 (0%) 0 (0%) 
SH:24 388 (88%) 11 (6%) 12 (63%) 1 (13%) 
Total  439 (100%) 173 (100%) 19 (100%) 8 (100%) 
Data are n (%). Percentages do not add up to 100% due to rounding.  
In the intervention group, 2.8% (12/432) of chlamydia tests were positive, 1.4% (6/433) of 
gonorrhoea tests were positive, 0.8% (3/363) of syphilis tests were positive. In the control 
group, 2.4% (4/169) of chlamydia tests were positive, 3% (5/169) of gonorrhoea tests were 
positive. None of the 137 (0/137) syphilis tests in the control arm were positive.  
365 participants tested for HIV in the intervention group and 140 in the control group. 
There were no confirmed HIV diagnoses. One participant tested for hepatitis B in the 
intervention group and 11 in the control group. There were no hepatitis B diagnoses in 
either group.    
Among participants who were diagnosed, most (24/27) were diagnosed with a single STI 
and three with more than one STI.   
5.4 Discussion 
5.4.1 Statement of principal findings  
When STI testing is promoted, offering e-STI testing alongside usual care significantly 
increases uptake of STI testing. The intervention increased STI testing in all groups including 
those at high risk for STIs.  Higher proportion of participants in the intervention arm tested 
for all infections, including HIV and syphilis, compared to the control arm.  
There was a lack of power for the analyses of STI diagnoses and STI cases treated, but the 
estimates are in the expected direction. The intervention reduced time-to-test but not time-
to-treatment. 
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5.4.2 Strength and weaknesses  
This study has several strengths. Randomisation was via an independent remote computer 
based randomisation system to ensure study staff had no prior knowledge of the treatment 
allocation. We collected objective outcomes even for those participants who tested outside 
of Lambeth and Southwark or via a different pathway (e.g. at the GP). Laboratory staff and 
researchers carrying out the analyses were blinded to the allocation. Baseline prognostic 
factors were well balanced between groups and our co-primary outcomes were known for 
84% of participants. In trials where it is not possible to blind participants, allocation to the 
control group could reduce motivation to carry out the desired behaviour. To mitigate 
potential performance bias, participants were informed at the time of recruitment that 
they would be invited via text message to use one type of sexual health service without 
stating the options.  All analyses were intention to treat as far as possible, as 9 participants 
were excluded from the analyses.   
The trial included high-risk groups including MSM (262/2,063; 13%), 16-24 year olds (1,298/ 
2,063; 63%) and individuals reporting two or more sexual partners in the last year 
(1,457/2,063; 71%). We enrolled individuals who reported limited prior contact with 
conventional STI testing services. A quarter of the study population had never tested for 
STIs prior to the trial (528/2,063) (Table 5). 17% of MSM (45/262) and 21% of 16-24 year 
olds (277/1,298)  had not tested within the last 12 months, despite national guidelines 
which recommend annual STI  testing among these groups (British HIV Association, British 
Association of Sexual Health and HIV & British Infection Society; Public Health England) 
The trial has a number of limitations.  We fell short of the recruitment target of 3,000 
participants and it was not possible to extend the recruitment period due to a pre-existing 
plan to promote SH:24 widely across the study area. As a result, the study lacked power to 
detect differences in STI diagnoses and STI cases treated.  
As with other online enrolment systems (Bailey et al. 2013), a high number of potential 
participants started, but did not complete, the enrolment process (Figure 13).  1,608 
potential participants consented to the study but were not randomised.  The reasons for 
this are unknown. It is plausible that interested individuals who were channelled from 
highly optimised social media platforms, such as twitter and Facebook, were put off by the 
enrolment website which was less user friendly. It is also possible that the requirement to 
submit baseline data was deemed cumbersome. We do not know if there were systematic 
99 
 
differences between those who continued to randomisation and those who dropped out. In 
order to minimise potential selection bias and reduce inefficiencies in the enrolment 
process, it will be important for future studies to monitor online enrolment procedures 
carefully to ensure that a higher proportion of consented participants are randomised. This 
point is particularly salient given that we were underpowered for our analyses of the co-
primary outcome of STI diagnoses.   
It is likely that those who enrolled in the study had a greater interest in STI testing than those 
who declined. Testing uptake in the control and intervention arms in all trials may be higher 
than in the general population.  This could result in a smaller risk difference if the intervention 
were to be implemented in the general population. 26% of our study population identified 
as BME at baseline. This is lower than the proportion of individuals in Lambeth and 
Southwark identifying as BME (44% and 48% respectively  (Southwark Council; Lambeth 
Council May, 2015)), which may limit the generalisability of the results. 
While there is some reporting bias in the self-reported data (Figure 14, Figure 15), the 
potential to bias the co-primary endpoints is limited, as these were objectively verified via 
participants’ health records.  
Only one scenario would result in any misclassification of the co-primary endpoints: if a 
participant tested at a service outside of Lambeth and Southwark, but told the study team 
they did not test. This scenario is judged to be fairly extreme, as it is reasonable to assume 
that participants were more likely to over-report than under-report the outcome of interest 
(STI testing), as this is the socially desirable behaviour in this context.  
There was potential for contamination as the URL for SH:24 was promoted in Lambeth and 
Southwark when the service was launched in March 2015.  However, only 11 control group 
participants used SH: 24 in the trial and any contamination would have biased our results 
towards the null. In the subgroup analyses there was no evidence of heterogeneity as a result 
of SH:24’s change in availability.   
At enrolment, participants were informed that the £10 incentive was for completing follow 
up, but some participants later reported that they thought it was for completing an STI test. 
Given that all participants were told about the £10 incentive, and sent money at follow up, 
the impact of this incentivisation should be non-differential and would not explain the 
statistically significant results.  
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Although the laboratory tests used by services are highly sensitive and specific, some 
misclassification is possible. This misclassification could have biased our STI diagnoses 
results towards the null. Eight people were randomised twice and therefore excluded from 
the analyses. It is possible other people were randomised twice but only if they used a false 
name and date of birth. All services were motivated to record STI testing data in line with 
national surveillance requirements. If some services were more accurate than others, this 
might result in differential misclassification and bias.   
Although there were high response rates for our co-primary outcomes, these rates were 
differential as there was higher follow up in the intervention group than in the control 
group. This can result in biased estimates under a complete case approach (Bell et al. 2013). 
To deal with missing outcome data, the primary analyses used multivariate imputation 
techniques under the assumption that data are MAR.  This approach is well-established and 
it is more valid and efficient than other approaches to deal with missing data (Carpenter & 
Kenward 2008).   It is reassuring that the results of all sensitivity analyses reported in the 
main trial paper (Wilson et al. 2017; Appendix 6) are similar to these results for the primary 
analyses  
5.4.3 Strengths and weaknesses in relation to other studies.  
To my knowledge, this is the first trial of an e-STI testing service, which offers testing for 
four STIs (chlamydia, gonorrhoea, HIV and syphilis). Descriptive studies from the United 
States suggest services that offer internet-based testing for chlamydia, gonorrhoea and 
trichomoniasis, can attract at-risk populations (young and black and minority ethnic groups) 
and yield high STI positivity (Chai et al. 2010; Ladd et al. 2014). One randomised controlled 
trial in France has evaluated self-sampling for chlamydia accessed via the internet 
compared to chlamydia testing in face-to-face settings. It reports an increase in testing 
uptake (29.2% in the intervention group v 8.7% in the control group, RR 3.37, 95% CI 3.05 – 
3.74).  However, outcomes were assessed using different measures in the intervention and 
control groups, and there was low and differential follow up (47% follow up in the 
intervention group v. 30% follow up in the control group) (Kersaudy-Rahib et al. 2017). 
Our findings for STI testing are similar to increases in testing reported in trials of self-
sampling and self-testing interventions that are not accessed via the internet (Fajardo-
Bernal et al. 2015; World Health Organisation 2016).  
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5.4.4 Meaning and mechanisms  
In chapter 3, I applied the candidacy lens to theorise how SH:24 may increase access and 
utilisation of STI testing in a complex service delivery system. Rather than viewing ‘access’ as 
a single event, the candidacy lens conceptualises the use of health care as a dynamic process 
of social interaction between patients and professionals (Mackenzie et al. 2013; Dixon-
Woods et al. 2005). Drawing on the initial theory of change and wider literature, I presented 
propositions for how SH:24 may prompt increased recognition of candidacy, and enable 
smoother negotiations of STI testing trajectories, leading to increased utilisation of STI testing 
services. While the study results are consistent with this conceptualisation, the RCT findings 
are unable to shed light on the precise change processes underlying the intervention, and 
further research is warranted.  
The similar effect of e-STI testing on testing uptake among different population groups is of 
public health importance as it suggests a potential to increase testing among groups with 
diverse risk profiles including those most at risk for STIs. Yet the way in which the intervention 
triggered increased recognition of candidacy among diverse socio-demographic groups, and 
their subsequent navigation of e-STI testing pathways, is unlikely to have been uniform. 
Investigation of possible variation in the negotiation of e-STI testing pathways may 
potentially illuminate inequalities that are obscured by the positive effects observed in this 
study.  
Seven of the 19 participants diagnosed in the intervention arm were diagnosed in a sexual 
health clinic. Those in the intervention arm who opted to test in clinic were at greater risk 
of an STI diagnosis, compared to those who opted to test via SH:24 (14%, (7/50) v 3.1%, 
(12/388)). It is not known if those who opted to test in clinic were prompted to do so by the 
SH:24 website (as they reported symptoms) or if they chose to test in clinic independently. 
This highlights the continued importance of face-to-face services and is consistent with the 
theory of change, which proposes that e- STI testing offers patients more choice.   
National guidelines in the UK recommend increasing testing among key population groups, 
and in areas of high HIV prevalence, in order to detect asymptomatic infection and normalise 
testing practices (Public Health England 2015b; National Institute for Health and Care 
Excellence 2016). The results for STI testing uptake suggest that e-STI testing could play a role 
in achieving these public health objectives. STI testing uptake and STI diagnoses are 
important intermediary outcomes on the pathway to increasing cases treated, cured and 
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managed in community settings. However, the study provides limited evidence on these 
latter outcomes.  
e-STI testing is currently being implemented in the UK as one measure to meet increasing 
demand for STI testing against a backdrop of severe budget cuts (Robertson et al. 2017; 
Cleary & O’Sullivan 2017). Publication of the cost-effectiveness evaluation of the intervention 
is pending and may provide additional insights on the contribution of e-STI testing.  A larger 
trial is required to assess outcomes later in the cascade of STI care including STI diagnoses, 
cases treated and cured.  
The effect size for STI cases treated was lower than our estimate for STI diagnoses, as it was 
not possible to confirm if all those diagnosed were treated.  At the time of the trial, SH:24 
required those diagnosed with an infection to attend clinics in person for treatment. 
Attendance at clinic for treatment was confirmed for 11 of 19 diagnosed in the intervention 
group and 7 of 8 people diagnosed in the control group.  
Some participants may have obtained treatment outside the study area. Five participants in 
the intervention arm reported (via the self-completed questionnaire or via telephone follow 
up) that they were treated (Table 10).   
Table 10. Self-reported attendance for treatment, among participants with missing treatment 
outcomes 
Reported place of treatment Intervention Control 
Sexual Health Clinic 3 - 
Pharmacy 1 - 
Online Pharmacy (Med Express) 1 - 
Not Stated 3 1 
Total 8 1 
However, these self-reported accounts could not be verified as not all named the precise 
service where they were treated; while others reported receiving treatment in a private 
service and the study ethical approval did not extend to these services.  
The intervention did not reduce time-to-treatment. It is plausible that whilst the intervention 
removed the barrier of having to attend a service for testing, the subsequent requirement to 
attend services for treatment may have deterred some participants.  This supports the 
processual framing of health service utilisation central to the candidacy model, as users with 
a positive or reactive result were required to negotiate and renegotiate both digital and face-
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to-face environments in their care-seeking for STIs. Additional inputs are required so that 
increases in STI testing and STI diagnoses translate into similar increases in cases treated. 
This is likely to ensure that the potential public health benefits of e-STI testing can be fully 
realised. 
5.5 Conclusions 
We trialled SH:24 in a community setting and in two boroughs well–served by face-to-face 
clinical services. Providing e- STI testing in contexts where supply is more limited, or 
targeting particular high risk groups might strengthen the contribution of e- STI testing to 
the control and management of STIs.     
e-STI testing models could be adapted for countries with sufficient laboratory facilities.  
Established distribution channels for health products may be suitable for sending and 
receiving test kits, where postal services are limited. Future iterations of e-STI testing could 
include a wider range of services such as self-testing for HIV.  Self-testing differs from the 
self-sampling modality evaluated by this study. Self-testing  enables individuals to take a 
sample, perform a test and interpret the results by themselves, without the need of a 
laboratory (Harding-Esch et al. 2016).  
Delivering e-STI testing and results services to scale is technically feasible as demonstrated 
by SH:24, which currently delivers 42,000 tests per year in six regions in the UK. The long-
term public health benefits of e-STI services will depend on testing, diagnosis and treatment 
rates when implemented. These outcomes should be subject to ongoing monitoring and 
evaluation.  
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6.1 Chapter overview  
In the previous chapter, I presented results for the main trial analyses. In this current 
chapter, I present the results and implications of a secondary analysis, which examines the 
effect of the intervention on STI testing on a subsample of participants who reported 
having never tested for STIs at baseline.  
6.2 Background 
As discussed in chapter 1, STI testing coverage in suboptimal in England. Both psychosocial 
and contextual factors inhibit access to face-to-face sexual health services (Oliver de Visser 
& O’Neill 2013; Deblonde et al. 2010). Self-sampling accessed via the internet (e-STI testing) 
may overcome some of these barriers, by enabling users to bypass the stigma, 
embarrassment and inconvenience associated with face-to-face STI testing (Minichiello et 
al. 2013; Hottes et al. 2012; Baraitser et al. 2015; Lorimer & McDaid 2013).  
Public Health England recommends e-STI testing to expand access to opportunistic 
screening for chlamydia and HIV, particularly for at-risk groups not reached by conventional 
services (National Institute for Health and Care Excellence 2016; Public Health England 
2015b).  Yet the evidence on the effectiveness of e-STI testing services to increase testing 
uptake among those who have never tested for STIs is extremely limited.        
One large observational study among MSM in Canada found that those who reported 
barriers in accessing testing services had higher odds of intending to use an e-STI service 
compared to those who did not report barriers [OR 1.65 95% CI 1.40-1.96] (Gilbert et al. 
2013). In the UK, descriptive data suggest that the national HIV e-testing service (test.hiv), 
which targets MSM and black African heterosexuals, can reach those who have never 
previously tested among these populations. Between November 2015 and October 2017, 
29.9% of the 44,660 returned kits were from first-time users who had never previously 
tested (Public Health England 2018a) . However, it is not known how this compares to the 
proportion of first-time testers who attend face-to-face services, as testing history is not 
routinely collected in these settings. 
In the previous chapters, I discussed the results of a large randomised controlled trial in an 
inner city area of London which demonstrated that e-STI testing increases uptake of testing 
at 6 weeks when offered alongside usual care in community settings (48.4% v 24.6%, 
relative risk 1.97, 95% confidence interval 1.74 to 2.22, p<0.001)(Wilson et al. 2017). The 
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trial sample included participants with a range of socio-demographic and behavioural 
characteristics, as well as testing profiles. For these secondary analyses, I examine the 
effect of offering e-STI testing on testing uptake at 6 weeks and time-to-test among trial 
participants who reported never having tested for an STI at baseline.  
6.3 Methods 
6.3.1 Study population  
I analysed a subsample of the main trial sample (n=528), who reported never having had an 
STI test at baseline.   
6.3.2 Outcomes  
The outcomes are: 1) the proportion of participants who tested for any STI at 6 weeks from 
randomisation, 2) time from randomisation to completion of an STI test in each arm.  
The process outcomes are the proportion who tested positive for any STI among 
participants who completed a test within 6 weeks; the proportion of participants who 
completed an STI test, by service type; the proportion who consider the intervention to be 
acceptable (intervention group only). 
In addition to these outcomes, I assess the proportion of participants who tested for HIV at 
6 weeks from randomisation and the proportion of participants who tested for chlamydia 
or gonorrhoea at 6 weeks from randomisation.  
6.3.3 Sample size 
The published trial results are as follows: 50.0% of the intervention group completed an STI 
test compared to 26.6% in the control group, RR 1.87, P<0.0001 (Wilson et al. 2017). I 
hypothesised that in this subpopulation, far fewer participants would complete an STI test 
in each arm, but that the relative effect of e-STI testing on testing uptake would be similar.  
A sample size of 420 would lead to 90% power (two-side alpha=5%) to detect a relative risk 
of 1.87. This equates to 28% of the intervention group completing a test compared to 15% 
in the control group.  
6.3.4 Statistical methods  
We adopted a similar statistical approach to the main trial analyses to ensure 
comparability. Randomisation was based on a minimisation algorithm to balance key 
prognostic covariates. This required an adjusted analysis.  
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Our analysis model used an inverse probability of treatment estimator, to estimate the 
average treatment effects (ATE).  Covariates included all minimisation factors (gender, age, 
sexual orientation and number of sexual partners in the last 12 months) in addition to 
ethnicity, as this is also a predictor of the outcome. The ATE was used to obtain the value of 
the weighted risk difference. I obtained estimates for the weighted risk ratio and its 
confidence intervals via the delta method of transformation. 
To account for missing outcome data (STI testing), I used multivariate imputation by 
chained equations assuming data are Missing at Random (MAR). In our imputation models, 
I conditioned on self-reported testing and diagnoses, which were also incomplete. I 
included randomised group as a covariate. This was weighted by the inverse of the 
propensity score to ensure compatibility with our model for analysis.  I generated 100 
imputed datasets and inference proceeded via Rubin’s rules (Rubin 1987).  
6.3.5 Missing covariates  
All baseline characteristics were fully observed, except for sexuality as participants could 
opt out of this question. A missing category was therefore used.  
6.3.6 Sensitivity analyses  
For the main trial, TM conducted a sensitivity analysis to explore departures from MAR for 
our co-primary outcomes. The results were similar to our estimates under MAR for all the 
scenarios we investigated (Wilson et al. 2017). For the purposes of these secondary 
analyses, we consider our assumption that data are MAR to be valid. 
6.3.7 Subgroup analyses 
To explore heterogeneity of the intervention effect on our outcome, I tested for interaction 
at a 5% level of significance to assess whether effectiveness varied by the following baseline 
characteristics: gender (male, female); ethnicity (Black/ Black British, White/ White British, 
Other); age (16-19; 20-24, 25-30 years); number of sexual partners in the last 12 months (1, 
2+),  sexuality msm, other); index of multiple deprivation (linear) and recruitment source 
(face-to-face; online). These analyses were conducted in the complete cases under a MAR 
assumption using a log binomial model.   
6.3.8 Time to event analyses 
I used survival analysis to estimate the restricted mean survival time from randomisation to 
completion of an STI test for each group. This is an appropriate measure even when the 
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proportional hazard assumption is in doubt (Royston & Parmar 2011). In the main trial 
analyses, the Kaplan Meier plots for our co-primary outcome (uptake of STI testing) 
suggested that the effect of the intervention was time-dependent. In these secondary 
analyses, the mean survival times were set to t* = 6 weeks (42 days), t*= 2 weeks (14 days), 
and t*= one week (7 days) to investigate possible time-dependency of the intervention 
among this sub-sample.  
I obtained ethical approval for these secondary analyses from the London School of 
Hygiene and Tropical Medicine Ethics Committee (Ref: 14414).   
6.4 Results 
Outcome data (STI testing) were available for 87% (213/244) of the intervention group and 
79% (224/284) of the control group.  
This subsample of first-time testers includes key prevention groups for STIs: 80% (420/528) 
are young adults aged between 16-24 years and 7% (35/528) are MSM. In addition over half 
(56%, 294/528) reported having at least two sexual partners in the last 12 months.  
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Baseline characteristics are presented in Table 11.  
Table 11. Baseline characteristics of participants – secondary analyses  
 
Intervention Group 
(n=244) 
Control Group 
(n=284) 
Sex   
Female 130 (53.3%) 142 (50.0%) 
Male 113 (46.3%) 141 (49.6%) 
Transgender 1 (<1%) 1 (<1%) 
Mean (age) 21.3 (3.5) 21.3 (3.6) 
Age group (years)   
16-19 years 96 (39.3%) 118 (41.5%) 
20-24 years 96 (39.3%) 110 (38.7%) 
25-30 years 52 (21.3%) 56 (19.7%) 
Sexual Orientation   
MSM 14 (5.7%) 21 (7.4%) 
Other 224 (91.8%) 258 (90.8%) 
Refused 6 (2.5%) 5 (1.8%) 
Partners in last 12 
months   
1 111 (45.5%) 123 (43.3%) 
2 or more 133 (54.5%) 161 (56.7%) 
Ethnic Group   
White/ White British 176 (72.1%) 194 (68.3%) 
Black/ Black British 18 (7.4%) 25 (8.8%) 
Asian/ Asian British 33 (13.5%) 34 (12.0%) 
Mixed/ Multiple ethnicity 14 (5.7%) 26 (9.2%) 
Other 3 (1.2%) 5 (1.8%) 
At 6 weeks, 45.3% of the intervention completed at least one STI test, compared to 24.1% of 
the control group (RR 1.88, 95% CI 1.47-2.40, p<0.001) (Table 12). For HIV testing alone, 
40.6% of the intervention completed an HIV test compared to 21.7% in the control group (RR 
1.87, 95% CI 1.44 -2.44, p<0.001). For chlamydia and gonorrhoea testing combined, 44.3% 
completed a test in the intervention compared to 24.1% in the control (RR 1.84, 95% CI 1.44-
2.36, p<0.001). 
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Table 12. Effect of SH:24 on testing uptake (MICE) – secondary analyses 
 Intervention Control Risk difference Relative risk P value 
   (95% CI) (95% CI)  
Uptake of testing (any 
STI) 
45.3% 24.1% 21.2% (12.5, 29.8) 1.88 (1.47, 2.40) <0.001 
Uptake of HIV testing 40.6% 21.7% 18.9% (10.3, 27.4) 1.87 (1.44, 2.44) <0.001 
Uptake of chlamydia 
and gonorrhoea testing 
44.3% 24.1% 20.2% (11.7, 28.8) 1.84 (1.44, 2.36) <0.001 
Similar results were observed for the analyses in the complete cases (Appendix 7).  In the 
complete cases, the intervention reduced time to test for any STI at 42 days, but not at 7 
and 14 days (Table 13).  
Table 13. Time to test (any STI) – secondary analyses 
 Intervention Control RMST difference P value  
RMST (SE) RMST (SE) (95% CI)  
Time to test (t*= 42 days) 29.0 (1.1) 36.3 (0.8) 7.3 days (4.6 to 10.0) <0.001 
Time to test (t*= 14 days) 12.2 (0.2) 12.9 (0.2) 0.7 days (0.1, 1.2) 0.21 
Time to test (t*= 7 days) 6.8 (0.04) 6.71 (0.07) -0.1 days (-0.25, 0.06) 0.22 
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There was no evidence of heterogeneity for the subgroup analyses (Figure 20). 
6.4.1 Process outcomes 
Among those who completed a test, 4.3% (4/94) of the intervention arm tested positive for 
an STI, compared to 2.3% (1/44) in the control.  89% (84/94) of those who tested in the 
intervention arm, tested via SH:24 (Table 14).  
Table 14. Service used for testing, by arm 
  Intervention  Control 
Sexual health clinic in Lambeth and 
Southwark  
9 (10%) 39 (89%) 
Other sexual health clinic  1 (1%) 1 (2%) 
GP 0 (0%) 1 (2%) 
SH:24 84 (89%) 3 (7%) 
Total who completed a test 94 (100%) 44 (100%) 
Figure 20. Effect of the intervention on STI testing uptake, by subgroup – secondary 
analyses 
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6.5 Discussion  
6.5.1 Statement of principal findings 
When promoted in community settings and delivered alongside usual care, e-STI testing 
increases testing uptake among those who had not previously attended STI testing services. 
Similar estimates were observed when I examined the effects on uptake of chlamydia and 
gonorrhoea testing, and uptake of HIV testing separately.   The intervention reduced time-
to-test. There was no evidence of heterogeneity for any of our subgroup analyses.  
6.5.2 Strengths and weaknesses 
The strengths of the main trial have been discussed in chapters four and five. Briefly, an 
independent remote computer based randomisation system was used, and laboratory and 
outcome assessors were blinded to allocation. Due to the nature of the intervention it was 
not possible to blind participants. To mitigate any performance bias, participants were 
informed at recruitment that they would be invited via text message to use one type of sexual 
health service without stating the options.   
The main outcome (uptake of any STI test) was known for 83% of participants in this 
subsample. In the main trial, a minimisation algorithm was used to balance key prognostic 
factors. In this study I analysed a sub-sample from the main trial sample, and therefore not 
all baseline characteristics were balanced (Table 11). I accounted for this in the analyses, by 
adjusting for baseline covariates (ethnicity, age, gender, sexuality and number of sexual 
partners in the last 12 months) via inverse probability of treatment weighting.  All analyses 
were intention to treat.  
6.5.3 Limitations 
Our study has several limitations. It was not possible to assess the effect on outcomes later 
in the cascade of care such as STI diagnoses and STI cases treated due to the size of the 
sample. Nevertheless undiagnosed infections were detected in this subpopulation. Of those 
who tested, 4.3% (4/94) in the intervention arm and 2.3% (1/44) in the control arm were 
diagnosed with an STI. Four participants were diagnosed with chlamydia and one with 
gonorrhoea. This underlines the importance of public health strategies to reach populations 
who do not access services.  
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We were underpowered for our subgroup analyses, which were exploratory in nature. 
Further research may be warranted to confirm no heterogeneity of effect among these 
subgroups of never testers.  
All services in this trial were required to record STI testing data. However if some services 
were more accurate than others, this could result in differential misclassification and bias.  
Secondary analyses of RCT data are recommended to generate additional insights beyond 
the primary research question, and to take full advantage of the potential richness of trial 
datasets (Ebrahim et al. 2016; National Institute for Health Research no date). In line with 
best practice, secondary hypotheses were specified and ethical approval was obtained prior 
to conducting these analyses. We also ensured that we had sufficient power to detect an 
effect of the intervention on STI testing in this subpopulation.  
6.5.4 Meaning and mechanisms 
To my knowledge, this is the first study to assess the effectiveness of an e-sexual health 
service among a subpopulation who had never tested for STIs. The intervention increased 
testing uptake for all STIs, including HIV. National guidelines recommend HIV testing in 
routine settings such as GPs and hospitals in areas of high prevalence (2 - 5 prevalent cases 
per 1,000 population, aged 15-59 years). Yet provider adherence to these guidelines can be 
variable (Elmahdi et al. 2014). Limited resources and expertise, combined with a reluctance 
to offer testing to patients perceived to be low risk may explain this variability (Burns et al. 
2007). Our findings would suggest that e-STI testing is a viable option for expanding and 
normalising HIV testing outside of specialist care, when combined with a health promotion 
message to encourage testing.    
The provision of chlamydia testing is widely available in non-specialist settings. In 2016, 
32% of chlamydia screening in England was conducted by GPs or by secondary level sexual 
and reproductive health clinics (Public Health England 2017d). The results for testing uptake 
for chlamydia and gonorrhoea, suggest that e-STI testing can reach young people who do 
not access these conventional screening services. The number of chlamydia cases (n=4) 
were too few to assess care pathways for those diagnosed by online and clinic services in 
this study. Results from a preliminary observational evaluation of an eSexual health clinic -  
offering web-based results and risk management, and remote treatment for chlamydia via 
pharmacy collection -  suggests that online treatment pathways are feasible for users of e-
STI testing services (Estcourt et al. 2017). 
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The overall effect estimate for STI testing (relative risk) is comparable in magnitude to the 
effect size from our main trial analyses and this was expected. The proportions who 
completed a test are also comparable, but this was not anticipated. It was assumed that 
this subpopulation would be more reluctant to accept the offer of a test. Our recruitment 
strategy may offer insights into how STI testing can be promoted to first time testers in 
community settings. Moreover, the subgroup analyses indicate that the intervention is 
effective irrespective of mode of recruitment (face-to-face or online).  
The effect of the intervention is time-dependent. There was a reduction in time-to-test at 
time horizons of 42 days but not at 14 and 7 days. While most participants in the 
intervention arm ordered the kits almost immediately after randomisation (median time <1 
day), they delayed in returning the kits to the laboratory to be processed (median time 
from kit order to kit return = 9 days). SH:24 sent reminder text messages at 2 weeks to all 
non-returners. Future iterations of e-STI testing services could reduce delays on the care 
pathway, by sending earlier and more frequent reminders. 
The barriers to seeking sexual health care are multifaceted and operate at individual, 
structural and societal levels (Deblonde et al. 2010; Oliver de Visser & O’Neill 2013). Over 
half (~55%) of the intervention group did not complete a test, which suggests that e-health 
services do not circumvent all obstacles associated with face-to-face care. Indeed, 
psychological barriers such a fear of a positive diagnosis are likely to persist.  Further 
research is needed to understand the precise mechanism of change among this 
subpopulation and why some non-attenders of face-to-face services declined the offer to 
test via an alternative testing pathway.  Moreover, both the recognition of candidacy and 
the subsequent navigation of clinical pathways may vary between populations with and 
without a prior history of STI testing.  
6.5.5 Conclusions  
Sexual health services in the UK are currently being reconfigured to include e-STI testing 
with a view to saving costs for routine asymptomatic testing and increasing access among 
hard-to-reach groups. This study has demonstrated that e-STI testing can increase testing 
uptake and reduce time-to-test among those who have never tested, when delivered 
alongside usual care.   
The findings lend weight to national policies in the UK, which promote e-STI testing as a 
measure to expand access to opportunistic testing for HIV and chlamydia. e-STI testing 
116 
 
services can be delivered to scale as demonstrated by SH:24 and national programmes such 
as test.hiv (HIV) and freetest.me (chlamydia). 
e-STI testing requires ongoing monitoring and evaluation. Larger studies are needed to 
assess outcomes later in the cascade of care such as STI diagnoses, cases treated and 
adherence to antiretroviral therapy for those diagnosed with HIV.   
6.6 Chapter summary 
I discussed the results of the main trial analyses in chapter 5 and in this chapter, I presented 
a secondary analysis, which examined the effect of STI testing on a subsample of 
participants who had not tested for STIs prior to their enrolment in the study. In the 
following chapter, I present my discussion for the whole thesis. I situate the findings from 
both the primary and secondary analyses within my theoretical framework and I outline the 
implications for public health policy in the UK. I end the chapter by outlining an agenda for 
further research in this area. 
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Chapter 7: Discussion 
7.1 Summary of findings 
When e-STI testing is promoted in community settings and delivered alongside usual care, it 
almost doubles uptake of STI testing.  The intervention increased STI testing in all groups 
including those at high risk for STIs.  The trial lacked power for the analyses of STI diagnoses 
and STI cases treated, but these estimates were of the expected magnitude and in the 
expected direction. The effect of the intervention was time-dependent. The intervention 
reduced time-to-test but not time-to-treatment. 
Secondary analyses of the RCT data examined the effect of the intervention among a 
subsample of trial participants who reported never testing for STIs at baseline.  The 
intervention increased uptake of testing among this subsample. Similar estimates were 
observed for both uptake of chlamydia and gonorrhoea testing, and uptake of HIV testing.   
The intervention reduced time-to-test. As in the main trial analyses, no heterogeneity was 
observed in the subgroup analyses.  
7.2 Meaning and mechanisms  
The main trial results are consistent with the causal pathway stipulated in the original 
funding proposal and the theory of change, which proposed that introducing e-STI testing 
within a complex service delivery system would increase access to, and subsequently 
utilisation of, STI testing services. It was hypothesised that this would result in an increased 
proportion of STI cases diagnosed and treated in the population. Whilst the results are 
consistent with this hypothesis, the precise effects remain uncertain.  
Increased access to STI testing is a key intermediary outcome on this hypothesised causal 
pathway. I utilised the candidacy lens to understand the construct of ‘access’ within a 
sexual health service delivery system. Rather than viewing access as a one-off event, the 
candidacy framework emphasises the processual nature of health service utilisation - one 
that is underpinned by continual interaction and negotiation between patients (or users) 
and health professionals.  Arguably this processual framing of access is particularly 
applicable in this current context, given that clinical care pathways traverse both online and 
face-to-face environments. This necessitates that users negotiate and renegotiate both 
environments in their care-seeking for STIs.  
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In my theoretical framework, I drew on a critical realist perspective to theorise how SH:24 
would lead to changes in STI testing behaviours. In line with the stratified ontology of 
critical realism (Bhaskar 2008), causal mechanisms are conceived as ‘latent powers and 
capabilities’ rather than tangible intervention inputs or activities. These latent powers are 
considered  ‘a function of the interaction between intervention resources and responses of 
participants’ (Van Belle et al. 2016, p.3).  
In considering the possible causal mechanisms underpinning SH:24, I proposed that both 
the awareness and availability of the intervention would trigger increased recognition of 
candidacy. Recognition of candidacy is the process through which individuals identify that 
they have a legitimate claim to health services, prompting health-seeking actions. I posited 
that this increased recognition of candidacy would occur, as e-STI testing pathways would 
be perceived to be better aligned with the population’s health-seeking preferences. Given 
that these preferences are patterned by demographic and psychosocial factors, the way in 
which intervention components triggered recognition of candidacy is likely to have varied 
across individuals and groups of individuals.  
Almost a quarter of the control arm in the main trial analyses, accepted the offer to 
complete an STI test. This suggests that additional mechanisms were at play in this context. 
The health promotion message which accompanied the offer to enrol in the trial may have 
influenced perceived need for STI testing among participants in both groups (and hence 
their identification of candidacy). The cash incentive may also have triggered a response in 
both arms. Understanding the role of health promotion in decisions to seek an STI test is of 
public health importance, particularly among those who reported never testing for STIs 
prior to the study. However, it may also be the case, that for some participants, their 
decision to test and their subsequent choice of service, were influenced by mechanisms 
that are not associated with the study nor the intervention.  
It was beyond the scope of the thesis to test and explore the causal processes underlying 
the intervention. Nevertheless my conceptual model provides an explanatory framework 
within which to situate the evaluation findings. In line with realist evaluative approaches, I 
outlined several contextual contingencies that may influence the effectiveness of the 
intervention, and the way intervention mechanisms may operate. In the following section, I 
discuss each of these contingencies in light of the evaluation findings.   
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7.3 Contextual contingencies  
SH:24 aims to provide seamless pathways between online and face-to-face services. I 
proposed that the navigation of online pathways was contingent on the integration of these 
two service environments, and whether care pathways would be acceptable to participants. 
The main trial findings suggest that in some cases, adjudications on the continued 
candidacy of participants were resisted. A higher proportion of those diagnosed in the 
intervention arm declined the treatment pathway that was offered at the point of 
diagnosis, compared to the control arm. Whilst it is not known if these participants sought 
treatment elsewhere, participants’ resistance to these referral pathways may indicate that 
these care options were not aligned with their health-seeking preferences.  
Macdonald and colleagues (Macdonald et al. 2016) describe the point of diagnosis as a 
‘critical juncture’ in the navigation of services. They distinguish between negotiations of 
candidacy pre and post diagnosis, as they found that post-diagnostic negotiation is greatly 
influenced by the social significance of the illness in question.  The stigma attached to STI 
diagnoses may introduce new barriers in the continued navigation of services. In the trial, 
these barriers may have been compounded by the requirement to obtain treatment in face-
to-face settings, which necessitated the negotiation of a new service environment.  These 
findings suggested that additional inputs may be required to ensure that a higher 
proportion of cases diagnosed via e-STI testing are subsequently treated. 
The service delivery system for sexual health in Lambeth and Southwark has changed 
substantially since completing the trial. Due to local authority cuts in sexual health funding, 
three sexual health clinics in Lambeth and Southwark were closed in 2017; and STI testing 
in existing services is subject to new restrictions and protocols. Individuals who attend GUM 
clinics are triaged and those without symptoms are supported by a health worker to use 
SH:24 (Turner et al. 2018). At the same time, SH:24 has been forced to implement a daily 
cap on the number of orders in Lambeth and Southwark, in order to ensure they do not 
surpass their commissioning agreement. 
This presents a new and challenging funding and service environment. The RCT findings 
showed that when delivered alongside usual care, e-STI testing increased uptake of testing, 
and this increased utilisation may incur a modest public health benefit, with respect to 
cases diagnosed and treated.  Yet it is possible that changing local conditions could 
threaten the potential benefits of e-STI testing. Those seeking STI testing in clinic settings 
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need to do more to demonstrate their qualification for candidacy (i.e. demonstrate STI 
symptoms).  In the trial, 50 participants allocated to the intervention, declined the offer to 
test in SH:24 and chose to use a clinic service, yielding 11 of the 19 diagnoses in the 
intervention arm. This suggests that choice, and ease of navigation between face-to-face 
and online care pathways, may have contributed to the effects observed.  Given the new 
qualifications to service use, it is unclear whether in this new funding environment, the 
potential benefits of e-STI testing will be fully realised.   
7.4 Policy implications 
The findings lend weight to national policies in the UK, which promote e-STI testing as a 
measure to expand access to HIV testing. It is particularly encouraging that the intervention 
increased uptake of HIV testing among those who had never previously tested. Nationally, 
provider adherence to guidelines for routine HIV testing outwith of specialist settings is 
variable (Elmahdi et al. 2014). Our findings suggest that e-STI testing is a viable option for 
expanding and normalising HIV testing outside of GUM settings, in areas of high HIV 
prevalence.  
The similar effect observed for uptake of chlamydia testing among never testers, suggests 
that e-STI testing can reach young people who have yet to be screened for chlamydia in 
face-to-face services. e-STI testing is recommended by the National Chlamydia Screening 
Programme to expand access to opportunistic screening. However in routine settings, 
uptake of this testing modality is low, relative to GP and other specialist services - only 8% 
of all chlamydia tests were carried out via internet-accessed pathways in 2016.  
 The findings may have implications for the way e-STI testing is promoted to increase 
chlamydia screening. In the trial, intervention participants were made aware of the SH:24 
service via text message.  In routine settings, young people may lack awareness of STI 
testing modalities on offer. Further, SH:24 is based on a user-led design and it is subject to 
continuous testing and optimisation. Commissioned e-STI testing services may vary in 
quality, not only in terms of specific service components, but also with respect to the 
design and functionality of the websites.  
e-STI testing is increasingly viewed by sexual health commissioners as one measure to meet 
increasing demand for STI testing in a context of severe budget cuts (Robertson et al. 2017). 
SH:24 was trialled in a community setting and in two boroughs that were well–served by 
face-to-face clinical services. Providing e- STI testing in contexts where supply is more 
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limited, or targeting particular high risk groups might strengthen the contribution of e- STI 
testing to the control and management of STIs.  In the trial, STI positivity in the intervention 
arm was lower than in routine GP and clinic settings in Lambeth and Southwark. 
Observational studies have also found that users of SH:24 continue have lower STI positivity 
than GUM patients (Turner et al. 2018). An observational study has examined the cost-
effectiveness of SH:24, and will account for this lower positivity. Publication of this study is 
pending and may provide additional insights on the contribution of e-STI testing. 
e-STI testing does not circumvent all barriers to STI testing. Almost 56% (119/213) of 
participants allocated to the intervention, who had never previously tested, did not accept 
the offer the test in an e-STI testing service; of whom 83% (99/119) were aged 16-24 years 
of age and 45% (53/119) had changed partners in the last year. Exploration of persistent 
barriers to STI testing is warranted. 
Since implementing the trial, pathways to care are increasingly adjudicated by health 
professionals, who have been assigned new gate-keeping roles in this current funding 
environment. The adjudication of candidacy to specific care pathways appears to be based 
on a biomedical model (i.e. presence of symptoms), rather than patients’ own assessment 
of need. This development may compromise opportunities for patient empowerment and 
patient-centred care within sexual health. Moreover, national standards for STI testing 
precede these current funding challenges (British Association for Sexual Health and HIV & 
Medical Foundation for HIV & Sexual Health 2014). It may be important to question 
whether new gate-keeping roles, and restrictions on patient choice, serve to undermine 
quality standards.  
7.5 Limitations and challenges 
It was not feasible to continue recruiting beyond August 2015 as SH:24 began to expand 
their marketing strategy in line with their funding agreement, and the risk of contamination 
was too high. Furthermore, once launched, SH:24 was keen to increase the functionality of 
the website and adapt the service, in line with their test-build-learn philosophy. We 
therefore did not recruit to target and we were underpowered for the analyses of STI 
diagnoses and cases treated.  
The effectiveness of interventions in research contexts may differ from their effectiveness 
when implemented in routine settings. It is probable that trial participants were more 
motivated to complete an STI test than individuals in routine settings. While we succeeded 
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in recruiting participants with a range of socio-demographic characteristics and testing 
histories, we struggled to recruit high numbers of participants from non-white ethnic 
backgrounds. No heterogeneity was observed for the effect of SH:24 on testing uptake 
across the ethnicity subgroup. However, the trial was not specifically powered for these 
analyses, and therefore these findings are not conclusive. Observational data has shown 
that a lower proportion of SH:24 users are from minority black ethnic backgrounds 
compared to attendees of GUM clinics (Barnard et al. 2018; Turner et al. 2018). Given the 
rapid and extensive changes to the commissioning and service delivery environment, it will 
be important to monitor utilisation patterns across different subgroups, and to understand 
persistent and changing barriers to care.  
The precise mechanism or mechanisms triggered by SH:24 in this complex service delivery 
system remain unexplored. As a result, the ‘core functions’ of the intervention (Hawe 
2015), which may facilitate replication in different social settings, are not known. 
Nevertheless my explanatory framework for the intervention can provide a platform for 
future research. I discuss directions for future research below in section 7.7.   
7.6 Reflections  
There is some debate on the benefits of minimisation as a method of allocation in RCTs 
(Scott et al. 2002; Proschan, Brittain & Kammerman 2011; Berger 2011). Minimisation can 
ensure that treatment arms are balanced with respect to known prognostic factors and can 
be advantageous in small trials (Altman & Bland 2005).  However, in larger trials, simple 
randomisation may be preferable followed by adjustment for chance imbalances. 
Unmeasured characteristics are more likely to be balanced via simple randomisation than 
via minimisation; and the benefits of minimisation can be negated given that an adjusted 
analysis is required to account for correlation in data between treatment groups (Morris 
2012).  
Clinical trials often fail to recruit ethnically diverse samples and this study was no 
exception. If I were to repeat the trial and this PhD, I would spend more time fostering 
relationships with further education colleges in Lambeth and Southwark, as a high 
proportion of students at these institutions are from BME backgrounds.  
With more time and resources, I would have designed and implemented a mixed method 
study for this PhD. This would include formative work to develop hypotheses on how the 
offer and availability of e-STI testing triggers increased recognition of candidacy and how 
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this process might vary among according to individuals’ socio-demographic characteristics, 
risk profiles, and STI testing histories. I would then have tested these propositions 
empirically via qualitative investigation with trial participants. Such investigation may have 
illuminated the causal mechanisms of the intervention, adding richness to the RCT findings 
while also facilitating replication of the intervention to other social settings.   
7.7 Future research 
A larger trial is required to understand the effects of e-STI testing on outcomes later in the 
cascade of care including STI cases diagnosed, treated, cured and managed in community 
settings. There were no HIV diagnoses in the trial. Further research is needed to establish if 
those diagnosed with HIV via e-STI testing pathways seek timely treatment.  
It has been beyond the scope of this thesis to generate additional data to investigate the 
causal processes underlying the intervention. Further research is required to understand 
how candidacy is recognised and negotiated in a digital service environment by different 
risk groups and in varied contexts. This should include formative qualitative investigation to 
develop hypotheses that can be tested empirically. Arguably however, there is a need to 
explore candidacy with respect to both online and face-to-face entry points to STI care 
pathways, particularly in light of recent funding cuts. In the study context of Lambeth and 
Southwark, individuals who are asymptomatic and who attend face-to-face clinical services 
for STI testing, are now triaged in clinic and channelled towards SH:24. The impact of these 
new protocols on the ability of patients to assert their claims to candidacy, and the ensuing 
implications for equity in sexual health care, warrant investigation.  
A recent observational study found that between July and September 2016, almost a third 
of attendees of the Camberwell sexual health centre in South London who were triaged and 
signposted to SH:24 did not complete a test and it is not known if they sought care 
elsewhere (Turner et al. 2018). As highlighted in the original theory of change, a key 
concern is to understand what opportunities may be lost by shifting patterns of service use, 
and the reduction of face-to-face interaction with health professionals (Baraitser et al. 
2015).  
Longitudinal research can generate insights into the dynamic and adaptive features of the 
STI testing service delivery system. The introduction e-STI testing may lead to changes in 
patient-provider relations across the entire system, as the clinical encounter for STI testing 
is transferred into a digital space, characterised by remote interaction between patients 
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and professionals. Moreover, as STI testing becomes a habitual activity, and one that 
increasingly takes place in domestic rather than clinical spaces, this may in turn may have 
implications for the social significance of STI testing.  
This thesis examined the effect of a specific model of e-STI testing that provided postal self-
sampling test kits for chlamydia, gonorrhoea, HIV, and syphilis, results delivered via text 
message or telephone, and web-based safer sex health information. Other models of e-STI 
testing are being piloted both in the UK and internationally, and are subject to evaluative 
work (Spielberg et al. 2014; Estcourt et al. 2017). These investigations may generate 
additional insights on the contribution of e-STI testing to population health. e-STI testing 
services should be subject to ongoing monitoring and evaluation, particularly as services 
develop and adapt.   
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 Complete case analyses – never testers 
Weighted complete case analyses – never testers 
  Intervention Control Risk difference Relative risk P value 
   (95% CI) (95% CI)  
      
Any STI test 44.1% 
(94/213) 
19.6% 
(44/224) 
24.9% (16.7, 33.0) 2.26 (1.59, 2.93) <0.0001 
HIV 39.4% 
(84/213) 
17.9% 
(40/224) 
21.9% (13.9,29.9) 2.22 (1.51,2.92) <0.0001 
Chlamydia 
and 
Gonorrhoea 
43.2% 
(92/213) 
19.6% 
(44/224) 
24.0% (15.9,32.1) 2.22(1.56, 2.88) <0.0001 
 
 
 
